Rank,Term name,P-value,Z-score,Combined score,Overlapping genes,Adjusted p-value,Old p-value,Old adjusted p-value,gene count
1,Cytoplasmic Ribosomal Proteins WP477,6.088867211877266e-16,6.925822932160641,242.64550990783823,"['RPL32', 'RPL34', 'RPLP1', 'RPL12', 'RPL36A', 'RPL10A', 'RPL9', 'RPL7', 'RPS15', 'RPS15A', 'RPS18', 'RPL35', 'RPL38', 'RPL37', 'RPS2', 'RPS11', 'RPS27A', 'RPL39', 'RPS10', 'RPS13', 'RPS12', 'RPL19', 'RPS9', 'RPL41', 'RPL21', 'RPL35A', 'RPSA', 'RPS3A', 'RPL23A', 'RPS26', 'RPS25', 'RPS27', 'RPS29', 'RPL37A', 'RPL24', 'RPL26', 'FAU', 'RPS21', 'RPS23']",2.9835449338198607e-13,0,0,39
2,"GPCRs, Class A Rhodopsin-like WP455",1.525855027364739e-05,5.583103860341872,61.91869056527148,"['P2RY12', 'CX3CR1', 'P2RY13', 'CHRM3', 'GPR34', 'GPR65', 'GPR22', 'FPR1', 'ADRB2', 'OPRM1', 'CYSLTR1', 'HRH1', 'HRH2']",0.0027763444070746674,0,0,13
3,Mitochondrial CIV Assembly WP4922,1.69980269820898e-05,6.116124260355029,67.1698043022373,"['COX7B', 'PET100', 'NDUFA4', 'SCO2', 'COX4I1', 'COX7A2', 'COX14', 'COX6A1', 'HIGD1A', 'COX5B', 'COX6C', 'COX7C']",0.0027763444070746674,0,0,12
4,Electron Transport Chain (OXPHOS system in mitochondria) WP111,3.740136461624123e-05,2.99270442640333,30.507040458737468,"['COX7B', 'NDUFA7', 'NDUFA4', 'COX4I1', 'NDUFB2', 'ATP5MC3', 'COX7A2', 'UQCR11', 'UQCR10', 'COX6A1', 'COX5B', 'COX6C', 'COX7A1', 'COX7C', 'UQCRH', 'ATP5F1E', 'ATP5MC1', 'ATP5IF1', 'UQCRQ', 'NDUFS6', 'NDUFAB1', 'UQCRFS1', 'ATP5MF']",0.003844824662349082,0,0,23
5,Development and heterogeneity of the ILC family WP3893,4.0622863204683444e-05,24.361764705882354,246.326176285666,"['NFIL3', 'IL15', 'ZBTB16', 'IL1B', 'ID2', 'RORA']",0.003844824662349082,0,0,6
6,Lung fibrosis WP3624,4.7079485661417326e-05,6.785597112860892,67.60947210219565,"['CEBPB', 'SERPINA1', 'IL1B', 'FAM13A', 'PDGFB', 'SPP1', 'HMOX1', 'ATP11A', 'IGF1', 'FGF2']",0.003844824662349082,0,0,10
7,Complement system WP2806,6.659652309926021e-05,4.6098974204901495,44.33272975176435,"['SELPLG', 'CD93', 'PROS1', 'FPR1', 'F13A1', 'C5', 'FCGR3A', 'ITGAX', 'SPP1', 'VSIG4', 'CALR', 'CD55', 'TLR2']",0.004661756616948214,0,0,13
8,Nuclear Receptors Meta-Pathway WP2882,0.00012728416644449807,2.2671199611461876,20.333999435590066,"['SERPINA1', 'ABCB4', 'PDGFB', 'MGST1', 'TNFAIP3', 'SLC2A3', 'SLC2A5', 'SLC5A3', 'DNAJB1', 'SEC14L1', 'FTH1', 'ENC1', 'PDE4B', 'HMOX1', 'JUNB', 'PLTP', 'ABCC3', 'CPT1A', 'HSP90AA1', 'STAT3', 'NRG1', 'SLC6A6', 'SLC7A5', 'SLC5A9', 'SCD', 'IL1B', 'BHLHE40', 'CPEB4', 'PPARD', 'HSPA1A', 'FKBP5', 'FTL']",0.007796155194725507,0,0,32
9,Vitamin D Receptor Pathway WP2877,0.000701249585970423,2.9007700770077007,21.06726820270996,"['CDKN1A', 'TNFAIP3', 'ADRB2', 'HIF1A', 'CRACR2A', 'DUSP10', 'BCL6', 'S100A6', 'SPP1', 'CD9', 'PRKCQ', 'CD14', 'JUNB', 'S100A9', 'S100A8', 'PPARD']",0.038179144125056366,0,0,16
10,NRF2 pathway WP2884,0.0010255412371237224,2.776658942489994,19.110451714829242,"['ABCC3', 'HSP90AA1', 'SERPINA1', 'PDGFB', 'SLC2A3', 'NRG1', 'SLC2A5', 'SLC5A3', 'SLC6A6', 'DNAJB1', 'SLC5A9', 'FTH1', 'HMOX1', 'FTL', 'PPARD', 'HSPA1A']",0.0502515206190624,0,0,16
11,Nonalcoholic fatty liver disease WP4396,0.0013435951559516595,2.1304216616716616,14.087213629029097,"['COX7B', 'COX4I1', 'NDUFB2', 'COX7A2', 'UQCR11', 'UQCR10', 'COX6A1', 'COX5B', 'COX7A1', 'COX7C', 'UQCRH', 'LEPR', 'UQCRFS1', 'XBP1', 'NDUFA7', 'NDUFA4', 'INSR', 'COX6C', 'VMP1', 'UQCRQ', 'NDUFS6', 'DDIT3', 'IL1B', 'NDUFAB1', 'CYCS']",0.05985105694693756,0,0,25
12,Differentiation Pathway WP2848,0.0015268990276927903,6.9563025210084035,45.10825763865447,"['WNT2B', 'NOTCH1', 'WNT5A', 'PDGFB', 'IGF1', 'FGF2']",0.06234837696412227,0,0,6
13,Monoamine GPCRs WP58,0.0018311441867049113,16.20939334637965,102.16479567332837,"['CHRM3', 'HRH1', 'HRH2', 'ADRB2']",0.06902005011426204,0,0,4
14,"GPCRs, Other WP117",0.0029483710140655863,4.735933922145895,27.593930646691486,"['CHRM3', 'ADGRE2', 'P2RY13', 'ADRB2', 'GRM1', 'ADGRL2', 'GPR135']",0.09631345312614248,0,0,7
15,Photodynamic therapy-induced unfolded protein response WP3613,0.0029483710140655863,4.735933922145895,27.593930646691486,"['DNAJC3', 'XBP1', 'HSPA5', 'DDIT3', 'DNAJB11', 'CALR', 'HSP90B1']",0.09631345312614248,0,0,7
16,Genes targeted by miRNAs in adipocytes WP1992,0.0039003178227982227,10.804957599478147,59.93182845365399,"['HDAC4', 'TMSB4X', 'IGF1', 'KCNJ2']",0.11242092548065466,0,0,4
17,Platelet-mediated interactions with vascular and circulating cells WP4462,0.0039003178227982227,10.804957599478147,59.93182845365399,"['SELPLG', 'IL1B', 'TLR4', 'TLR2']",0.11242092548065466,0,0,4
18,IL1 and megakaryocytes in obesity WP2865,0.004203853448309691,6.75726412014365,36.974084860959714,"['IL1B', 'NLRP3', 'PLA2G7', 'S100A9', 'TLR2']",0.11443823275954158,0,0,5
19,Spinal Cord Injury WP2431,0.0048729637853515235,2.580405942262779,13.73821786095566,"['TNFSF13', 'OMG', 'MIF', 'LILRB3', 'TNFSF13B', 'RHOB', 'ZFP36', 'C5', 'GAP43', 'FCGR2A', 'IL1B', 'APEX1', 'TLR4']",0.12567117130643404,0,0,13
20,Endochondral Ossification with Skeletal Dysplasias WP4808,0.006204803356753271,3.1789149672951136,16.156617730661285,"['HDAC4', 'SCIN', 'SPP1', 'ENPP1', 'PLAT', 'IGF1', 'FGF2', 'SLC38A2', 'CALM2']",0.13391948333888065,0,0,9
21,Endochondral Ossification WP474,0.006204803356753271,3.1789149672951136,16.156617730661285,"['HDAC4', 'SCIN', 'SPP1', 'ENPP1', 'PLAT', 'IGF1', 'FGF2', 'SLC38A2', 'CALM2']",0.13391948333888065,0,0,9
22,Extracellular vesicles in the crosstalk of cardiac cells WP4300,0.006559321632924766,5.791241080173499,29.111804993145412,"['STAT3', 'SPP1', 'HSPB1', 'IGF1', 'TLR4']",0.13391948333888065,0,0,5
23,"Oligodendrocyte specification and differentiation, leading to myelin components for CNS WP4304",0.006559321632924766,5.791241080173499,29.111804993145412,"['IL1B', 'PDGFB', 'OMG', 'IGF1', 'FGF2']",0.13391948333888065,0,0,5
24,Vitamin B12 metabolism WP1533,0.006559321632924766,5.791241080173499,29.111804993145412,"['IL1B', 'INSR', 'PLAT', 'APOE', 'SOD2']",0.13391948333888065,0,0,5
25,Development of pulmonary dendritic cells and macrophage subsets WP3892,0.007123624881166632,8.102739726027398,40.06268855483825,"['BATF3', 'ID2', 'STAT3', 'TCF4']",0.139623047670866,0,0,4
26,Selenium Micronutrient Network WP15,0.008115441303859326,2.8020635351615533,13.489096585897428,"['SELENOM', 'PRDX5', 'RFK', 'IL1B', 'INSR', 'SELENOW', 'PLAT', 'SOD2', 'ALOX15B', 'SELENOH']",0.15294485534196423,0,0,10
27,Cardiac Progenitor Differentiation WP2406,0.0097045946385761,5.066723800195886,23.485054369285255,"['NOTCH1', 'NRG1', 'ROR2', 'IGF1', 'FGF2']",0.16983040617508174,0,0,5
28,Mitochondrial complex III assembly WP4921,0.0097045946385761,5.066723800195886,23.485054369285255,"['UQCRQ', 'UQCRFS1', 'UQCR11', 'UQCR10', 'UQCRH']",0.16983040617508174,0,0,5
29,PTF1A related regulatory pathway WP4147,0.011241571869396493,12.14516129032258,54.50914287889681,"['NOTCH1', 'PROX1', 'RBPJ']",0.1748390147572778,0,0,3
30,PI3K-Akt signaling pathway WP4172,0.011374249828477224,1.7087785459878484,7.649181863216065,"['CDKN1A', 'LAMA2', 'PDGFB', 'LPAR1', 'FGF2', 'HSP90B1', 'GNG10', 'CCND3', 'GNG3', 'PDGFC', 'SPP1', 'FGF20', 'ITGAV', 'JAK3', 'IFNAR2', 'HSP90AA1', 'IL4R', 'INSR', 'IGF1', 'EPOR', 'FGF14', 'DDIT4', 'GRB2', 'SGK1', 'PIK3AP1', 'TLR4', 'TLR2']",0.1748390147572778,0,0,27
31,LTF danger signal response pathway WP4478,0.011714360251562623,6.481409001956947,28.82243576660727,"['IL1B', 'CD14', 'TLR4', 'TLR2']",0.1748390147572778,0,0,4
32,Peptide GPCRs WP24,0.011714360251562623,6.481409001956947,28.82243576660727,"['CX3CR1', 'FPR1', 'OPRM1', 'TSHR']",0.1748390147572778,0,0,4
33,Osteoblast Signaling WP322,0.012131686738260093,inf,inf,"['PDGFB', 'ITGAV']",0.1748390147572778,0,0,2
34,Thyroxine (Thyroid Hormone) Production WP1981,0.012131686738260093,inf,inf,"['TG', 'TSHR']",0.1748390147572778,0,0,2
35,MAPK Signaling Pathway WP382,0.015656218322635206,1.6565738671001828,6.886190544978426,"['LRRK2', 'PDGFB', 'CACNA1B', 'CACNA1A', 'HSPB1', 'CACNA1C', 'FGF2', 'RASGRP3', 'RPS6KA5', 'DUSP10', 'STMN1', 'FGF20', 'MAP3K8', 'CD14', 'MAP2K6', 'HSPA6', 'PLA2G4C', 'CACNA2D3', 'TGFBR1', 'CACNB4', 'FGF14', 'DDIT3', 'IL1B', 'RASA2', 'GRB2', 'HSPA1B', 'HSPA1A']",0.21796878011917686,0,0,27
36,Focal Adhesion-PI3K-Akt-mTOR-signaling pathway WP3932,0.016066046984090615,1.6701417322834646,6.899434187784361,"['CDKN1A', 'LAMA2', 'PDGFB', 'LPAR1', 'SLC2A3', 'HIF1A', 'FGF2', 'HSP90B1', 'GNG10', 'GNG3', 'PDGFC', 'SPP1', 'FGF20', 'ITGAX', 'ITGAV', 'JAK3', 'IFNAR2', 'HSP90AA1', 'IL4R', 'INSR', 'IGF1', 'EPOR', 'FGF14', 'PIK3IP1', 'DDIT4', 'GRB2']",0.21796878011917686,0,0,26
37,IL-18 signaling pathway WP4754,0.016458867070223558,1.685091767736396,6.920488072484049,"['SPON1', 'CEBPB', 'NRN1', 'HSPB8', 'RGS16', 'TNFAIP2', 'HSPB1', 'TNFAIP3', 'PLA2G7', 'GRM7', 'TMSB4X', 'STMN1', 'NFKBIZ', 'SPP1', 'HMOX1', 'RPS11', 'IER3', 'CPT1A', 'TICAM2', 'SEMA6D', 'GRIN2B', 'IL1B', 'CYCS', 'KIFC3', 'CDK5R2']",0.21796878011917686,0,0,25
38,Iron metabolism in placenta WP2007,0.017843903820310775,5.400521852576647,21.743005126695074,"['STEAP3', 'FTH1', 'SLC40A1', 'HAMP']",0.2300924439987442,0,0,4
39,HIF1A and PPARG regulation of glycolysis WP2456,0.02065202739246036,8.095796676441838,31.41121981250807,"['LDHA', 'TPI1', 'HIF1A']",0.2468169127391604,0,0,3
40,"Metabolic pathway of LDL, HDL and TG, including diseases WP4522",0.02065202739246036,8.095796676441838,31.41121981250807,"['LIPC', 'LIPG', 'APOE']",0.2468169127391604,0,0,3
41,Nanomaterial-induced inflammasome activation WP3890,0.02065202739246036,8.095796676441838,31.41121981250807,"['IL1B', 'CASP1', 'TLR4']",0.2468169127391604,0,0,3
42,Adipogenesis WP236,0.023252164070881407,2.0318361303060217,7.64246119982794,"['CDKN1A', 'CEBPB', 'WNT5B', 'CEBPD', 'STAT3', 'RORA', 'MIF', 'IGF1', 'HIF1A', 'SCD', 'DDIT3', 'NAMPT', 'PPARD']",0.2712752474936164,0,0,13
43,STING pathway in Kawasaki-like disease and COVID-19 WP4961,0.024907259857587617,3.6835544475113524,13.601878261969027,"['GSDMD', 'FCGR2A', 'IL1B', 'NLRP3', 'IKBKE']",0.27737630295949844,0,0,5
44,Type I collagen synthesis in the context of Osteogenesis imperfecta WP4786,0.024907259857587617,3.6835544475113524,13.601878261969027,"['P4HA1', 'P3H2', 'P3H1', 'TNFRSF11A', 'PPIB']",0.27737630295949844,0,0,5
45,Glycolysis and Gluconeogenesis WP534,0.028780579433378393,2.7033038927052666,9.591469391427283,"['LDHA', 'TPI1', 'MPC2', 'PGAM1', 'SLC2A3', 'ALDOC', 'SLC2A5']",0.3118079546967852,0,0,7
46,Activation of NLRP3 Inflammasome by SARS-CoV-2 WP4876,0.033215836702721796,6.071114369501466,20.67049616719243,"['IL1B', 'CASP1', 'NLRP3']",0.3118079546967852,0,0,3
47,ApoE and miR-146 in inflammation and atherosclerosis WP3926,0.033215836702721796,6.071114369501466,20.67049616719243,"['APOE', 'TLR4', 'TLR2']",0.3118079546967852,0,0,3
48,Dual hijack model of Vif in HIV infection WP3300,0.033215836702721796,6.071114369501466,20.67049616719243,"['ELOB', 'ELOC', 'RUNX1']",0.3118079546967852,0,0,3
49,FGF23 signaling in hypophosphatemic rickets and related disorders WP4790,0.033215836702721796,6.071114369501466,20.67049616719243,"['CDKN1A', 'SPP1', 'ENPP1']",0.3118079546967852,0,0,3
50,"GPCRs, Class B Secretin-like WP334",0.033215836702721796,6.071114369501466,20.67049616719243,"['ADGRE2', 'CALCR', 'ADGRL2']",0.3118079546967852,0,0,3
51,"GPCRs, Class C Metabotropic glutamate, pheromone WP501",0.033215836702721796,6.071114369501466,20.67049616719243,"['GRM5', 'GRM7', 'GRM1']",0.3118079546967852,0,0,3
52,Transcriptional cascade regulating adipogenesis WP4211,0.033215836702721796,6.071114369501466,20.67049616719243,"['CEBPB', 'CEBPD', 'DDIT3']",0.3118079546967852,0,0,3
53,EV release from cardiac cells and their functional effects WP3297,0.03372616652842778,16.1796875,54.840748027899416,"['CXCL12', 'RGS16']",0.3118079546967852,0,0,2
54,ESC Pluripotency Pathways WP3931,0.03959775823140104,1.9844553913519432,6.407772271752523,"['FGF14', 'WNT2B', 'WNT5B', 'WNT5A', 'STAT3', 'PDGFB', 'FGF20', 'GAB1', 'GRB2', 'FGF2', 'MAP2K6']",0.35931299135900946,0,0,11
55,Glucocorticoid Receptor Pathway WP2880,0.044952996682992845,2.237246798997358,6.94024798224727,"['HSP90AA1', 'MGAM', 'SEC14L1', 'ENC1', 'BHLHE40', 'PDE4B', 'TNFAIP3', 'CPEB4']",0.4004903340848453,0,0,8
56,Eicosanoid metabolism via lipooxygenases (LOX) WP4721,0.04649910441226737,3.599043270276147,11.04302446041547,"['CYSLTR1', 'LTC4S', 'ALOX15B', 'PPARD']",0.404009190801271,0,0,4
57,Nuclear Receptors in Lipid Metabolism and Toxicity WP299,0.04887118915966953,4.8563049853372435,14.659083111295102,"['ABCC3', 'ABCB4', 'PPARD']",0.404009190801271,0,0,3
58,Osteoclast Signaling WP12,0.04887118915966953,4.8563049853372435,14.659083111295102,"['PDGFB', 'SPP1', 'TNFRSF11A']",0.404009190801271,0,0,3
59,Toll-like Receptor Signaling Pathway WP75,0.04957848370927189,1.8381154404376465,5.522063346715345,"['IFNAR2', 'TICAM2', 'IL1B', 'SPP1', 'LY96', 'MAP3K8', 'CD14', 'TLR5', 'IKBKE', 'TLR4', 'MAP2K6', 'TLR2']",0.404009190801271,0,0,12
60,Fibrin Complement Receptor 3 Signaling Pathway WP4136,0.050016960018293484,2.5591331269349844,7.6656097889769725,"['TICAM2', 'IRAK2', 'LY96', 'PLAT', 'CD14', 'TLR4']",0.404009190801271,0,0,6
61,Neovascularisation processes WP4331,0.050295021711994965,2.8931719602630475,8.650147809239073,"['NOTCH1', 'CXCL12', 'PDGFB', 'HIF1A', 'TGFBR1']",0.404009190801271,0,0,5
62,Apoptosis-related network due to altered Notch3 in ovarian cancer WP2864,0.051665145646148034,2.1624099541584805,6.407159909414107,"['BEX3', 'CDKN1A', 'HSPA5', 'HSPB1', 'NRG1', 'APOE', 'YBX3', 'IER3']",0.40832131236471836,0,0,8
63,Arrhythmogenic Right Ventricular Cardiomyopathy WP2118,0.05898968707066272,2.0924012928575957,5.922317231298365,"['RYR2', 'CACNB4', 'LAMA2', 'CACNA2D3', 'ITGAV', 'CTNNA3', 'CACNA1C', 'ACTG1']",0.43892049964780616,0,0,8
64,Myometrial relaxation and contraction pathways WP289,0.059370818345033965,1.6247524752475249,4.588223728213039,"['RYR2', 'PDE4D', 'RGS16', 'LPAR1', 'ACTG1', 'RGS4', 'GNG3', 'ADCY9', 'IL1B', 'PDE4B', 'PRKCQ', 'CALM3', 'CALM2', 'RAMP1', 'RGS6', 'YWHAH']",0.43892049964780616,0,0,16
65,Pre-implantation embryo WP3527,0.059599203823793606,3.238747553816047,9.133634286417523,"['ESRRA', 'ZFP36', 'BATF3', 'DDIT3']",0.43892049964780616,0,0,4
66,Striated Muscle Contraction Pathway WP383,0.059599203823793606,3.238747553816047,9.133634286417523,"['TMOD1', 'MYOM1', 'ACTG1', 'TTN']",0.43892049964780616,0,0,4
67,Folate Metabolism WP176,0.061201940134856685,2.6999673522690175,7.542565044793857,"['RFK', 'IL1B', 'INSR', 'PLAT', 'SOD2']",0.43892049964780616,0,0,5
68,LncRNA-mediated mechanisms of therapeutic resistance WP3672,0.0625544243840844,8.0888671875,22.420061298939615,"['CDKN1A', 'HIF1A']",0.43892049964780616,0,0,2
69,miR-517 relationship with ARCN1 and USP1 WP3596,0.0625544243840844,8.0888671875,22.420061298939615,"['CDKN1A', 'ID2']",0.43892049964780616,0,0,2
70,PPAR signaling pathway WP3942,0.06427539676014936,2.182116705669208,5.988990274090394,"['CPT1A', 'FABP5', 'ACSL1', 'SCD', 'OLR1', 'PLTP', 'PPARD']",0.43892049964780616,0,0,7
71,Cell Differentiation - Index expanded WP2023,0.06744962646040088,4.046432062561095,10.910695154601934,"['ID2', 'STAT3', 'EZH2']",0.43892049964780616,0,0,3
72,Cori Cycle WP1946,0.06744962646040088,4.046432062561095,10.910695154601934,"['LDHA', 'TPI1', 'PGAM1']",0.43892049964780616,0,0,3
73,Leptin Insulin Overlap WP3935,0.06744962646040088,4.046432062561095,10.910695154601934,"['INSR', 'STAT3', 'LEPR']",0.43892049964780616,0,0,3
74,NOTCH1 regulation of endothelial cell calcification WP3413,0.06744962646040088,4.046432062561095,10.910695154601934,"['NOTCH1', 'LPAR1', 'PLAT']",0.43892049964780616,0,0,3
75,Pyrimidine metabolism and related diseases WP4225,0.06744962646040088,4.046432062561095,10.910695154601934,"['NT5C', 'DPYD', 'TYMP']",0.43892049964780616,0,0,3
76,TYROBP causal network in microglia WP3945,0.06807746525149647,1.843459198282033,4.95357585320192,"['IGSF6', 'ADAP2', 'DPYD', 'ITGAX', 'SPP1', 'HCLS1', 'TCIRG1', 'TNFRSF1B', 'GAL3ST4', 'TGFBR1']",0.43892049964780616,0,0,10
77,Calcium Regulation in the Cardiac Cell WP536,0.06921066117411005,1.5847379859937214,4.23220184384852,"['CHRM3', 'RYR2', 'RGS16', 'CACNA1B', 'CACNA1A', 'CACNA1C', 'ADRB2', 'RGS4', 'GNG3', 'ADCY9', 'PRKCQ', 'CALM3', 'CALR', 'CALM2', 'RGS6', 'YWHAH']",0.4404314801988821,0,0,16
78,Aryl Hydrocarbon Receptor Pathway WP2873,0.07333737329391699,2.530913320274241,6.612479097201588,"['SLC7A5', 'HSP90AA1', 'IL1B', 'MGST1', 'JUNB']",0.4448199178497547,0,0,5
79,Unfolded protein response WP4925,0.07333737329391699,2.530913320274241,6.612479097201588,"['XBP1', 'HSPA5', 'IL1B', 'DDIT3', 'TXNIP']",0.4448199178497547,0,0,5
80,Ferroptosis WP4313,0.07359278982474407,2.1010431432413768,5.482059044928593,"['STEAP3', 'MAP1LC3A', 'ACSL1', 'FTH1', 'SLC40A1', 'HMOX1', 'FTL']",0.4448199178497547,0,0,7
81,Oxysterols derived from cholesterol WP4545,0.07443925155853039,2.9439601494396017,7.647736955497933,"['CH25H', 'DBP', 'ACOT7', 'ACOT11']",0.4448199178497547,0,0,4
82,White fat cell differentiation WP4149,0.07443925155853039,2.9439601494396017,7.647736955497933,"['CEBPB', 'CEBPD', 'DDIT3', 'RORA']",0.4448199178497547,0,0,4
83,Epithelial to mesenchymal transition in colorectal cancer WP4239,0.07924362614691038,1.6786370128545194,4.2557280547550524,"['NOTCH1', 'WNT2B', 'WNT5B', 'ID2', 'WNT5A', 'GRB2', 'PROX1', 'RBPJ', 'HIF1A', 'TGFBR1', 'MAP2K6', 'EZH2']",0.4678238170118806,0,0,12
84,p38 MAPK Signaling Pathway WP400,0.08037831457903948,2.2093582887700536,5.569816235961951,"['RPS6KA5', 'DDIT3', 'HSPB1', 'GRB2', 'TGFBR1', 'MAP2K6']",0.46887350171106357,0,0,6
85,Biomarkers for pyrimidine metabolism disorders WP4584,0.08870924174800353,3.4679514034352743,8.400734975661,"['NT5C', 'DPYD', 'TYMP']",0.4990935383242073,0,0,3
86,Kynurenine Pathway and links to Cellular Senescence WP5044,0.08870924174800353,3.4679514034352743,8.400734975661,"['CDKN1A', 'HAAO', 'TLR4']",0.4990935383242073,0,0,3
87,Statin inhibition of cholesterol production WP430,0.09094992785402757,2.698303979125897,6.469038532876826,"['LIPC', 'APOC1', 'APOE', 'PLTP']",0.4990935383242073,0,0,4
88,Oxidative phosphorylation WP623,0.09336773091572083,1.7794085905460824,4.219350530888172,"['NDUFA7', 'NDUFS6', 'NDUFA4', 'NDUFAB1', 'NDUFB2', 'ATP5MC3', 'ATP5MF', 'ATP5F1E', 'ATP5MC1']",0.4990935383242073,0,0,9
89,Retinoblastoma gene in cancer WP2446,0.09336773091572083,1.7794085905460824,4.219350530888172,"['CDKN1A', 'CCND3', 'H2AFZ', 'PRIM1', 'RPA3', 'STMN1', 'HMGB2', 'E2F3', 'SAP30']",0.4990935383242073,0,0,9
90,Pathogenic Escherichia coli infection WP2272,0.09454794045283364,1.8523715969688466,4.369093056548282,"['TUBB2A', 'TUBB3', 'HCLS1', 'LY96', 'CD14', 'TLR5', 'TLR4', 'ACTG1']",0.4990935383242073,0,0,8
91,Regulatory circuits of the STAT3 signaling pathway WP4538,0.09454794045283364,1.8523715969688466,4.369093056548282,"['PTPRT', 'IFNAR2', 'STMN1', 'STAT3', 'IL21R', 'CSF2RB', 'JAK3', 'CSF2RA']",0.4990935383242073,0,0,8
92,Inflammatory Response Pathway WP453,0.09676303294040753,5.391927083333333,12.592793125096456,"['IL4R', 'TNFRSF1B']",0.4990935383242073,0,0,2
93,Insulin signaling in adipocytes (diabetic condition) WP3635,0.09676303294040753,5.391927083333333,12.592793125096456,"['TBC1D4', 'INSR']",0.4990935383242073,0,0,2
94,Insulin signaling in adipocytes (normal condition) WP3634,0.09676303294040753,5.391927083333333,12.592793125096456,"['TBC1D4', 'INSR']",0.4990935383242073,0,0,2
95,Mammary gland development pathway - Involution (Stage 4 of 4) WP2815,0.09676303294040753,5.391927083333333,12.592793125096456,"['STAT3', 'CHI3L1']",0.4990935383242073,0,0,2
96,MECP2 and Associated Rett Syndrome WP3584,0.10289047682430982,1.7368310155920776,3.949710371282057,"['RBFOX1', 'CEBPD', 'BCL6', 'YBX1', 'IGF1', 'SGK1', 'FGF2', 'FKBP5', 'EZH2']",0.5172223090614181,0,0,9
97,IL-4 signaling pathway WP395,0.10500214948506252,1.8006985374372408,4.058368369779942,"['CEBPB', 'HRH1', 'IL4R', 'NFIL3', 'FES', 'STAT3', 'GRB2', 'JAK3']",0.5172223090614181,0,0,8
98,CAMKK2  Pathway WP4874,0.10524608959272906,2.0247549019607844,4.558642443310681,"['HDAC4', 'CHRM3', 'FIS1', 'MAP1LC3A', 'HMOX1', 'CALM2']",0.5172223090614181,0,0,6
99,Endoplasmic reticulum stress response in coronavirus infection WP4861,0.10604087556438069,1.8902518809290154,4.2415941142005185,"['PPP1R14A', 'PPP1R14B', 'XBP1', 'MAP1LC3A', 'HSPA5', 'PPP1R3B', 'DDIT3']",0.5172223090614181,0,0,7
100,Regulation of toll-like receptor signaling pathway WP1449,0.10791951209457569,1.514361001317523,3.3715272787146104,"['IFNAR2', 'TICAM2', 'LY96', 'TNFAIP3', 'IRAK2', 'IL1B', 'SPP1', 'MAP3K8', 'CD14', 'TLR5', 'IKBKE', 'TLR4', 'MAP2K6', 'TLR2']",0.5172223090614181,0,0,14
101,Nuclear receptors WP170,0.10903645754306203,2.4904410657835316,5.518999153678272,"['ESRRA', 'RORA', 'NR1D2', 'PPARD']",0.5172223090614181,0,0,4
102,Codeine and Morphine Metabolism WP1604,0.11019199013549127,inf,inf,['ABCC3'],0.5172223090614181,0,0,1
103,"COVID-19, thrombosis and anticoagulation WP4927",0.11019199013549127,inf,inf,['F13A1'],0.5172223090614181,0,0,1
104,SCFA and skeletal muscle substrate metabolism WP4030,0.11019199013549127,inf,inf,['PPARD'],0.5172223090614181,0,0,1
105,7-oxo-C and 7beta-HC pathways WP5064,0.11236088627782981,3.034090909090909,6.632642236885574,"['DBP', 'ACOT7', 'ACOT11']",0.5172223090614181,0,0,3
106,Interactions between immune cells and microRNAs in tumor microenvironment WP4559,0.11236088627782981,3.034090909090909,6.632642236885574,"['IL4R', 'STAT3', 'TLR4']",0.5172223090614181,0,0,3
107,Thyroid hormones production and their peripheral downstream signaling effects WP4746,0.11294446340728927,1.6962337929615148,3.699246827378665,"['NHSL1', 'NOTCH1', 'TG', 'TBC1D4', 'ITGAV', 'PRKCQ', 'GRB2', 'MGLL', 'TSHR']",0.5172223090614181,0,0,9
108,Cardiac Hypertrophic Response WP2795,0.11606849807921513,1.7518186162586948,3.772672358647688,"['HDAC4', 'NRG1', 'IGF1', 'FGF2', 'IKBKE', 'CALM2', 'TGFBR1', 'MAP2K6']",0.520455245481984,0,0,8
109,Type 2 papillary renal cell carcinoma WP4241,0.11683689184289436,2.13052219186556,4.574180873367458,"['CDKN1A', 'PDGFB', 'ELOB', 'ELOC', 'HIF1A']",0.520455245481984,0,0,5
110,Type I interferon induction and signaling during SARS-CoV-2 infection WP4868,0.11683689184289436,2.13052219186556,4.574180873367458,"['IFNAR2', 'OAS1', 'IKBKE', 'TLR4', 'TLR2']",0.520455245481984,0,0,5
111,Host-pathogen interaction of human coronaviruses - MAPK signaling WP4877,0.11901036818708798,1.943529411764706,4.136889154936134,"['IFITM3', 'BST2', 'IFITM2', 'DDIT3', 'JUNB', 'MAP2K6']",0.5253610847898479,0,0,6
112,Circadian rhythm related genes WP3594,0.12740383840974231,1.4075261422705851,2.900057584408442,"['CPT1A', 'KCNH7', 'NR1D2', 'RORA', 'PROX1', 'CARTPT', 'TNFRSF11A', 'ARNTL', 'PER3', 'DBP', 'NFIL3', 'ID2', 'NAMPT', 'KCNMA1', 'BHLHE40', 'RPS27A', 'EZH2']",0.5546182533629881,0,0,17
113,Complement and Coagulation Cascades WP558,0.1285836365302968,2.3122728543472184,4.742877933220647,"['SERPINA1', 'PROS1', 'PLAT', 'CD55']",0.5546182533629881,0,0,4
114,Toll-like Receptor Signaling related to MyD88 WP3858,0.1335418813625121,2.023751224289912,4.0744995575930325,"['TICAM2', 'TLR5', 'IKBKE', 'TLR4', 'TLR2']",0.5546182533629881,0,0,5
115,Caloric restriction and aging WP4191,0.13481856385650604,4.04345703125,8.102381805647177,"['NAMPT', 'IGF1']",0.5546182533629881,0,0,2
116,Cells and molecules involved in local acute inflammatory response  WP4493,0.13481856385650604,4.04345703125,8.102381805647177,"['C5', 'SELPLG']",0.5546182533629881,0,0,2
117,Farnesoid X receptor pathway WP2879,0.13481856385650604,4.04345703125,8.102381805647177,"['ABCB4', 'FKBP5']",0.5546182533629881,0,0,2
118,Macrophage markers WP4146,0.13481856385650604,4.04345703125,8.102381805647177,"['CD163', 'CD14']",0.5546182533629881,0,0,2
119,Major receptors targeted by epinephrine and norepinephrine WP4589,0.13481856385650604,4.04345703125,8.102381805647177,"['ADCY9', 'ADRB2']",0.5546182533629881,0,0,2
120,Airway smooth muscle cell contraction WP4962,0.13808862634751948,2.6966438579341805,5.338976176114857,"['PPP1R14A', 'ADRB2', 'CALM2']",0.5546182533629881,0,0,3
121,Genes controlling nephrogenesis WP4823,0.13808862634751948,2.6966438579341805,5.338976176114857,"['ROBO2', 'CXCL12', 'PDGFB']",0.5546182533629881,0,0,3
122,Type II diabetes mellitus WP1584,0.13808862634751948,2.6966438579341805,5.338976176114857,"['GK', 'INSR', 'CACNA1A']",0.5546182533629881,0,0,3
123,Pyrimidine metabolism WP4022,0.14619727203694377,1.5850327048864947,3.0476983345724684,"['NT5C', 'POLE4', 'PRIM1', 'DPYD', 'ENPP1', 'POLR2I', 'POLR2K', 'NME1', 'TYMP']",0.5789740604089545,0,0,9
124,ncRNAs involved in Wnt signaling in hepatocellular carcinoma WP4336,0.14902723059648182,1.7991285403050108,3.424868287758777,"['CCND3', 'WNT2B', 'WNT5B', 'WNT5A', 'ROR2', 'EZH2']",0.5789740604089545,0,0,6
125,The Overlap Between Signal Transduction Pathways that Contribute to a Range of LMNA Laminopathies WP4879,0.14902723059648182,1.7991285403050108,3.424868287758777,"['CDKN1A', 'CEBPB', 'NOTCH1', 'CEBPD', 'SPP1', 'JUNB']",0.5789740604089545,0,0,6
126,Oxidative Stress WP408,0.14946060820980647,2.157860404435747,4.101493630750263,"['MGST1', 'HMOX1', 'SOD2', 'JUNB']",0.5789740604089545,0,0,4
127,Fatty acid beta-oxidation WP143,0.15124220353540035,1.9271489202928969,3.640139042716613,"['CPT1A', 'LIPC', 'TPI1', 'GK', 'ACSL1']",0.5789740604089545,0,0,5
128,Nucleotide-binding Oligomerization Domain (NOD) pathway WP1433,0.15124220353540035,1.9271489202928969,3.640139042716613,"['HSP90AA1', 'IL1B', 'CASP1', 'NLRP3', 'NLRP1']",0.5789740604089545,0,0,5
129,DNA damage response (only ATM dependent) WP710,0.16467528661792785,1.4610998950173626,2.6355023360761947,"['CCND3', 'CDKN1A', 'WNT2B', 'WNT5B', 'MLKL', 'BCL6', 'INSR', 'WNT5A', 'GRB2', 'SOD2', 'PDK1']",0.6099781321817821,0,0,11
130,G1 to S cell cycle control WP45,0.16519175732777447,1.7346638655462185,3.1235195652868564,"['CDKN1A', 'CCND3', 'PRIM1', 'RPA3', 'MCM5', 'E2F3']",0.6099781321817821,0,0,6
131,Simplified Depiction of MYD88 Distinct Input-Output Pathway WP3877,0.16556549302076942,2.4266862170087977,4.36412442615604,"['TLR5', 'TLR4', 'TLR2']",0.6099781321817821,0,0,3
132,Transcription factor regulation in adipogenesis WP3599,0.16556549302076942,2.4266862170087977,4.36412442615604,"['CEBPB', 'CEBPD', 'INSR']",0.6099781321817821,0,0,3
133,Wnt signaling in kidney disease WP4150,0.16556549302076942,2.4266862170087977,4.36412442615604,"['WNT2B', 'WNT5B', 'WNT5A']",0.6099781321817821,0,0,3
134,EPO Receptor Signaling WP581,0.17152528125740527,2.022749510763209,3.5661571686774014,"['STAT3', 'GRB2', 'EPOR', 'PDK1']",0.6185269044033258,0,0,4
135,Complement Activation WP545,0.1754596728817598,3.234375,5.628931744569411,"['C5', 'CD55']",0.6185269044033258,0,0,2
136,Cytokines and Inflammatory Response WP530,0.1754596728817598,3.234375,5.628931744569411,"['IL15', 'IL1B']",0.6185269044033258,0,0,2
137,Differentiation of white and brown adipocyte WP2895,0.1754596728817598,3.234375,5.628931744569411,"['PLAC8', 'CEBPB']",0.6185269044033258,0,0,2
138,LDLRAD4 and what we know about it WP4904,0.1754596728817598,3.234375,5.628931744569411,"['PMEPA1', 'TGFBR1']",0.6185269044033258,0,0,2
139,Regulation of sister chromatid separation at the metaphase-anaphase transition WP4240,0.1754596728817598,3.234375,5.628931744569411,"['BUB3', 'ANAPC11']",0.6185269044033258,0,0,2
140,Neural Crest Differentiation WP2064,0.18205956696241296,1.6746450304259635,2.85262610595298,"['HDAC4', 'NOTCH1', 'TCF4', 'RBPJ', 'FGF2', 'RHOB']",0.6372084843684453,0,0,6
141,Alzheimer's disease WP2059,0.1837785934696648,1.487448076575763,2.519772059632525,"['ATP5MD', 'VMP1', 'IL1B', 'CYCS', 'CALM3', 'CACNA1C', 'APOE', 'GRIN2B', 'CALM2']",0.6386631971640834,0,0,9
142,NO/cGMP/PKG mediated Neuroprotection WP4008,0.18931317111590473,1.7591449133415662,2.927837489783123,"['IL1B', 'TSPO', 'CYCS', 'GRIN2B', 'CALM2']",0.6508357945845524,0,0,5
143,VEGFA-VEGFR2 Signaling Pathway WP3888,0.19154855750680164,1.1769546734587721,1.945051698339705,"['HDAC4', 'FLII', 'PXN', 'HTRA1', 'HSPB1', 'IQGAP1', 'ADRB2', 'LDB2', 'RPL10A', 'SLC7A1', 'APOLD1', 'RPL7', 'ACTG1', 'SDCBP', 'LDHA', 'RPS6KA5', 'TMSB4X', 'ITGAV', 'ELOC', 'RPS11', 'TMSB10', 'CLIC1', 'MAP2K6', 'TMOD1', 'PTPN1', 'HSP90AA1', 'SDF2L1', 'SEMA6D', 'STAT3', 'GAB1', 'SOD2', 'PTPN14', 'INPP4B', 'KATNAL2', 'TXNIP', 'CYCS', 'GRB2', 'RPL26', 'CALR', 'PFN1', 'HSPA1A']",0.6508357945845524,0,0,41
144,IL-9 signaling pathway WP22,0.19446539700918686,2.2058117835243936,3.6120190877099554,"['STAT3', 'GRB2', 'JAK3']",0.6508357945845524,0,0,3
145,MFAP5 effect on permeability and motility of endothelial cells via cytoskeleton rearrangement WP4560,0.19446539700918686,2.2058117835243936,3.6120190877099554,"['PXN', 'ITGAV', 'PRKCQ']",0.6508357945845524,0,0,3
146,Purine metabolism and related disorders WP4224,0.19446539700918686,2.2058117835243936,3.6120190877099554,"['GRM5', 'IMPDH1', 'PAICS']",0.6508357945845524,0,0,3
147,Blood Clotting Cascade WP272,0.2082523313390894,8.081951219512195,12.68062028177195,['PLAT'],0.6508357945845524,0,0,1
148,Catalytic cycle of mammalian Flavin-containing MonoOxygenases (FMOs) WP688,0.2082523313390894,8.081951219512195,12.68062028177195,['FMO4'],0.6508357945845524,0,0,1
149,Composition of Lipid Particles WP3601,0.2082523313390894,8.081951219512195,12.68062028177195,['APOE'],0.6508357945845524,0,0,1
150,COVID-19 adverse outcome pathway WP4891,0.2082523313390894,8.081951219512195,12.68062028177195,['IL1B'],0.6508357945845524,0,0,1
151,Drug Induction of Bile Acid Pathway WP2289,0.2082523313390894,8.081951219512195,12.68062028177195,['ABCC3'],0.6508357945845524,0,0,1
152,Gene regulatory network modelling somitogenesis  WP2854,0.2082523313390894,8.081951219512195,12.68062028177195,['NOTCH1'],0.6508357945845524,0,0,1
153,Hfe effect on hepcidin production WP3924,0.2082523313390894,8.081951219512195,12.68062028177195,['HAMP'],0.6508357945845524,0,0,1
154,Secretion of Hydrochloric Acid in Parietal Cells WP2597,0.2082523313390894,8.081951219512195,12.68062028177195,['HRH2'],0.6508357945845524,0,0,1
155,Small Ligand GPCRs WP247,0.2082523313390894,8.081951219512195,12.68062028177195,['LPAR1'],0.6508357945845524,0,0,1
156,Somitogenesis in the context of spondylocostal dysostosis WP4785,0.2082523313390894,8.081951219512195,12.68062028177195,['NOTCH1'],0.6508357945845524,0,0,1
157,Hepatitis C and Hepatocellular Carcinoma WP3646,0.2095118318515999,1.6856431603003592,2.634618227356383,"['CDKN1A', 'STAT3', 'GRB2', 'HIF1A', 'TGFBR1']",0.6508357945845524,0,0,5
158,MicroRNAs in cardiomyocyte hypertrophy WP1544,0.21097593704818973,1.428769737983689,2.223181706572644,"['HDAC4', 'WNT5A', 'STAT3', 'NRG1', 'IGF1', 'FGF2', 'IKBKE', 'CALM2', 'MAP2K6']",0.6508357945845524,0,0,9
159,Fatty acid transporters WP5061,0.21765584405480373,2.6949869791666665,4.109424378247442,"['FABP5', 'ACSL1']",0.6508357945845524,0,0,2
160,Hijack of ubiquitination by SARS-CoV-2 WP4860,0.21765584405480373,2.6949869791666665,4.109424378247442,"['ELOB', 'ELOC']",0.6508357945845524,0,0,2
161,IL-10 Anti-inflammatory Signaling Pathway  WP4495,0.21765584405480373,2.6949869791666665,4.109424378247442,"['STAT3', 'HMOX1']",0.6508357945845524,0,0,2
162,Leptin and adiponectin WP3934,0.21765584405480373,2.6949869791666665,4.109424378247442,"['CPT1A', 'LEPR']",0.6508357945845524,0,0,2
163,Melatonin metabolism and effects WP3298,0.218616693269465,1.7975646879756468,2.733080880593946,"['PER3', 'APOE', 'CALM2', 'ARNTL']",0.6508357945845524,0,0,4
164,Signal transduction through IL1R WP4496,0.218616693269465,1.7975646879756468,2.733080880593946,"['IRAK2', 'IL1B', 'IL1RAP', 'MAP2K6']",0.6508357945845524,0,0,4
165,Ectoderm Differentiation WP2858,0.22273413111018917,1.331279889762503,1.999284794759914,"['SDCBP', 'PTPRB', 'PLCXD3', 'MAFB', 'ZBTB16', 'PIM1', 'HMGB2', 'SORCS1', 'ROR2', 'LDB2', 'KIFC3', 'PPARD']",0.6508357945845524,0,0,12
166,Angiogenesis WP1539,0.22447193731589662,2.0217497556207236,3.0205033953869447,"['PDGFB', 'HIF1A', 'FGF2']",0.6508357945845524,0,0,3
167,Gastric Cancer Network 2 WP2363,0.22447193731589662,2.0217497556207236,3.0205033953869447,"['PLAC8', 'RNF144B', 'S100A6']",0.6508357945845524,0,0,3
168,Hereditary leiomyomatosis and renal cell carcinoma pathway WP4206,0.22447193731589662,2.0217497556207236,3.0205033953869447,"['LDHA', 'HIF1A', 'PDK1']",0.6508357945845524,0,0,3
169,Immune response to tuberculosis WP4197,0.22447193731589662,2.0217497556207236,3.0205033953869447,"['IFNAR2', 'OAS1', 'PTPN2']",0.6508357945845524,0,0,3
170,Exercise-induced Circadian Regulation WP410,0.2363078474582342,1.5170955882352941,2.1885922639667004,"['CEBPB', 'BTG1', 'TUBB3', 'NR1D2', 'ERC2', 'ARNTL']",0.6771394459329518,0,0,6
171,Genotoxicity pathway WP4286,0.2363078474582342,1.5170955882352941,2.1885922639667004,"['ITPKC', 'CDKN1A', 'RPS27', 'CEBPD', 'ID2', 'PCDH8']",0.6771394459329518,0,0,6
172,Sudden Infant Death Syndrome (SIDS) Susceptibility Pathways WP706,0.2499758258026134,1.3095769342219648,1.81558575737263,"['RYR2', 'SNAP25', 'CPT1A', 'CEBPB', 'IL1B', 'BHLHE40', 'RORA', 'YBX1', 'HIF1A', 'HSP90B1', 'YWHAH']",0.6977062054680779,0,0,11
173,Phosphodiesterases in neuronal function WP4222,0.25177933031337696,1.5556015972274542,2.145489220598185,"['ADCY9', 'PDE4D', 'PDE4B', 'PDE7B', 'GRIN2B']",0.6977062054680779,0,0,5
174,7q11.23 copy number variation syndrome WP4932,0.2524392961821476,1.3269652768813733,1.8266797928219536,"['GRIP1', 'SNAP25', 'VPS9D1', 'BCL7B', 'ATP5MC3', 'DDX21', 'GRB2', 'NRG1', 'ATP5F1E', 'ATP5MC1']",0.6977062054680779,0,0,10
175,FBXL10 enhancement of MAP/ERK signaling in diffuse large B-cell lymphoma WP4553,0.2552847099042003,1.8660049627791564,2.5477981069873064,"['BCL6', 'H2AFZ', 'EZH2']",0.6977062054680779,0,0,3
176,Fluoropyrimidine Activity WP1601,0.2552847099042003,1.8660049627791564,2.5477981069873064,"['ABCC3', 'DPYD', 'TYMP']",0.6977062054680779,0,0,3
177,Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4) WP2817,0.2552847099042003,1.8660049627791564,2.5477981069873064,"['PTPN1', 'CEBPB', 'TNFRSF11A']",0.6977062054680779,0,0,3
178,Parkin-Ubiquitin Proteasomal System pathway WP2359,0.2559381815709747,1.377419219997492,1.8771735549194855,"['TUBB2A', 'HSPA5', 'TUBB3', 'HSPA6', 'CASP1', 'STUB1', 'HSPA1B', 'HSPA1A']",0.6977062054680779,0,0,8
179,Computational Model of Aerobic Glycolysis WP4629,0.2605719093890985,2.3097098214285716,3.1062742577773257,"['LDHA', 'TPI1']",0.6977062054680779,0,0,2
180,MFAP5-mediated ovarian cancer cell motility and invasiveness WP3301,0.2605719093890985,2.3097098214285716,3.1062742577773257,"['PRKCQ', 'ITGAV']",0.6977062054680779,0,0,2
181,ncRNAs involved in STAT3 signaling in hepatocellular carcinoma WP4337,0.2605719093890985,2.3097098214285716,3.1062742577773257,"['STAT3', 'JAK3']",0.6977062054680779,0,0,2
182,Overview of nanoparticle effects WP3287,0.2605719093890985,2.3097098214285716,3.1062742577773257,"['CCND3', 'HMOX1']",0.6977062054680779,0,0,2
183,Tryptophan catabolism leading to NAD+ production WP4210,0.2605719093890985,2.3097098214285716,3.1062742577773257,"['HAAO', 'NAMPT']",0.6977062054680779,0,0,2
184,Vitamin D-sensitive calcium signaling in depression WP4698,0.26863667848683226,1.6174168297455969,2.12592532162352,"['GRM5', 'ATP2B4', 'CACNA1C', 'GRIN2B']",0.7153911546660207,0,0,4
185,Oncostatin M Signaling Pathway WP2374,0.27412599006925237,1.381268101199167,1.78759223080807,"['CEBPB', 'PXN', 'STAT3', 'GRB2', 'JAK3', 'JUNB', 'HIF1A']",0.7203049723511324,0,0,7
186,Allograft Rejection WP2328,0.27489189761155464,1.427508650519031,1.8434523499060802,"['C5', 'CXCL12', 'GNLY', 'LRRK2', 'IL1B', 'CD55']",0.7203049723511324,0,0,6
187,LncRNA involvement in canonical Wnt signaling and colorectal cancer WP4258,0.27489189761155464,1.427508650519031,1.8434523499060802,"['CCND3', 'WNT2B', 'WNT5B', 'WNT5A', 'ROR2', 'EZH2']",0.7203049723511324,0,0,6
188,Breast cancer pathway WP4262,0.2809934395240395,1.2845269341332333,1.630609263357035,"['CDKN1A', 'NOTCH1', 'WNT2B', 'WNT5B', 'WNT5A', 'FGF20', 'GRB2', 'E2F3', 'IGF1', 'FGF2']",0.7290853490900856,0,0,10
189,NRF2-ARE regulation WP4357,0.2866236196931908,1.732509426057813,2.1649184036707556,"['CEBPB', 'INSR', 'HMOX1']",0.7290853490900856,0,0,3
190,Insulin Signaling WP481,0.289030111401661,1.1994132746607995,1.48874102770543,"['SNAP25', 'PTPN1', 'XBP1', 'INSR', 'GAB1', 'RPS6KA5', 'TBC1D4', 'ENPP1', 'FLOT2', 'MAP3K8', 'PRKCQ', 'GRB2', 'STX4', 'SGK1', 'SH2B2', 'MAP2K6']",0.7290853490900856,0,0,16
191,Metapathway biotransformation Phase I and II WP702,0.2921240433221811,1.3482172064115145,1.6590847630179275,"['NDST3', 'CYP51A1', 'MGST1', 'FMO4', 'SULT4A1', 'HS3ST4', 'GAL3ST4']",0.7290853490900856,0,0,7
192,Biogenic Amine Synthesis WP550,0.2955154163381184,4.040487804878048,4.925493114382252,['GAD2'],0.7290853490900856,0,0,1
193,Dopaminergic Neurogenesis WP2855,0.2955154163381184,4.040487804878048,4.925493114382252,['STAT3'],0.7290853490900856,0,0,1
194,Folate-Alcohol and Cancer Pathway Hypotheses WP1589,0.2955154163381184,4.040487804878048,4.925493114382252,['CEBPB'],0.7290853490900856,0,0,1
195,Nephrogenesis WP5052,0.2955154163381184,4.040487804878048,4.925493114382252,['FGF20'],0.7290853490900856,0,0,1
196,Autosomal recessive Osteopetrosis pathways WP4788,0.3035375739068928,2.020751953125,2.409241261793105,"['TNFRSF11A', 'TCIRG1']",0.7290853490900856,0,0,2
197,Development of ureteric collection system WP5053,0.3035375739068928,2.020751953125,2.409241261793105,"['ROBO2', 'GRIP1']",0.7290853490900856,0,0,2
198,Glycolysis in senescence WP5049,0.3035375739068928,2.020751953125,2.409241261793105,"['LDHA', 'ALDOC']",0.7290853490900856,0,0,2
199,miRNAs involved in DNA damage response WP1545,0.3035375739068928,2.020751953125,2.409241261793105,"['CDKN1A', 'CCND3']",0.7290853490900856,0,0,2
200,"NAD metabolism, sirtuins and aging WP3630",0.3035375739068928,2.020751953125,2.409241261793105,"['NAMPT', 'HIF1A']",0.7290853490900856,0,0,2
201,Osteopontin Signaling WP1434,0.3035375739068928,2.020751953125,2.409241261793105,"['SPP1', 'ITGAV']",0.7290853490900856,0,0,2
202,PPAR-alpha pathway WP2878,0.3035375739068928,2.020751953125,2.409241261793105,"['CPT1A', 'PLTP']",0.7290853490900856,0,0,2
203,Proteoglycan biosynthesis WP4784,0.3035375739068928,2.020751953125,2.409241261793105,"['CSGALNACT1', 'CHSY1']",0.7290853490900856,0,0,2
204,Urea cycle and metabolism of amino groups WP497,0.3035375739068928,2.020751953125,2.409241261793105,"['ARG2', 'OAT']",0.7290853490900856,0,0,2
205,Wnt signaling pathway and pluripotency WP399,0.3055737815269639,1.2943025540275048,1.534478537499769,"['CCND3', 'WNT2B', 'WNT5B', 'RACGAP1', 'LRRK2', 'WNT5A', 'PRKCQ', 'PPARD']",0.7303958680400601,0,0,8
206,Notch Signaling Pathway Netpath WP61,0.3148109330375116,1.3478758169934641,1.5578519997851363,"['CDKN1A', 'NOTCH1', 'STAT3', 'RBPJ', 'HIF1A', 'SAP30']",0.7475815026450703,0,0,6
207,TNF-alpha signaling pathway WP231,0.316424527256829,1.2552639609398841,1.444395242602815,"['HSP90AA1', 'RFK', 'TNFAIP3', 'MAP3K8', 'GRB2', 'PYGL', 'KSR2', 'TNFRSF1B', 'MAP2K6']",0.7475815026450703,0,0,9
208,PKC-gamma calcium signaling pathway in ataxia WP4760,0.3182316125331209,1.616813294232649,1.8512121273746016,"['CACNA1A', 'GRM1', 'PDK1']",0.7475815026450703,0,0,3
209,Hematopoietic Stem Cell Differentiation WP2849,0.32039207256217295,1.470023127557374,1.6731947394343378,"['NOTCH1', 'IL1B', 'PIM1', 'RUNX1']",0.7475815026450703,0,0,4
210,Oxidative Damage WP3941,0.32039207256217295,1.470023127557374,1.6731947394343378,"['CDKN1A', 'C5', 'CYCS', 'TNFRSF1B']",0.7475815026450703,0,0,4
211,ERK Pathway in Huntington's Disease WP3853,0.34602127526980975,1.7960069444444444,1.9060213796323706,"['RPS6KA5', 'GRM1']",0.7783927016285586,0,0,2
212,Omega-9 FA synthesis WP4724,0.34602127526980975,1.7960069444444444,1.9060213796323706,"['ACSL1', 'SCD']",0.7783927016285586,0,0,2
213,Phytochemical activity on NRF2 transcriptional activation WP3,0.34602127526980975,1.7960069444444444,1.9060213796323706,"['CEBPB', 'HMOX1']",0.7783927016285586,0,0,2
214,NAD Metabolism in Oncogene-Induced Senescence and Mitochondrial Dysfunction-Associated Senescence WP5046,0.34987616989050546,1.5155791788856305,1.5916248606897345,"['SCO2', 'IL1B', 'NAMPT']",0.7783927016285586,0,0,3
215,Nanoparticle triggered autophagic cell death WP2509,0.34987616989050546,1.5155791788856305,1.5916248606897345,"['VMP1', 'MAP1LC3A', 'INSR']",0.7783927016285586,0,0,3
216,Regulation of Actin Cytoskeleton WP51,0.3532155615482397,1.1694589006915235,1.2170286909296546,"['CHRM3', 'FGF14', 'TMSB4X', 'PXN', 'PDGFB', 'FGF20', 'IQGAP1', 'CD14', 'PFN1', 'SSH2', 'FGF2', 'ACTG1']",0.7783927016285586,0,0,12
217,Modulators of TCR signaling and T cell activation WP5072,0.35555274931180053,1.276625386996904,1.3201348995399633,"['RASA2', 'TNFAIP3', 'ELOB', 'MAP3K8', 'PRKCQ', 'GRB2']",0.7783927016285586,0,0,6
218,Cell cycle WP179,0.36474694726672824,1.1930944436384738,1.2032971442419929,"['ANAPC13', 'CCND3', 'CDKN1A', 'CHEK2', 'MCM5', 'E2F3', 'BUB3', 'ANAPC11', 'YWHAH']",0.7783927016285586,0,0,9
219,Acute viral myocarditis WP4298,0.36618659915097307,1.2303835815164057,1.236058408046985,"['LAMA2', 'STAT3', 'CASP1', 'CYCS', 'TLR5', 'TLR4', 'CD55']",0.7783927016285586,0,0,7
220,Non-small cell lung cancer WP4255,0.36618659915097307,1.2303835815164057,1.236058408046985,"['CDKN1A', 'STAT3', 'CYCS', 'E2F3', 'GRB2', 'JAK3', 'PDK1']",0.7783927016285586,0,0,7
221,Cholesterol Biosynthesis with Skeletal Dysplasias WP4804,0.3731690641148627,2.6933333333333334,2.6548825175946282,['CYP51A1'],0.7783927016285586,0,0,1
222,Liver X receptor pathway WP2874,0.3731690641148627,2.6933333333333334,2.6548825175946282,['SCD'],0.7783927016285586,0,0,1
223,MicroRNA for Targeting Cancer Growth and Vascularization in Glioblastoma WP3593,0.3731690641148627,2.6933333333333334,2.6548825175946282,['HIF1A'],0.7783927016285586,0,0,1
224,miR-509-3p alteration of YAP1/ECM axis WP3967,0.3731690641148627,2.6933333333333334,2.6548825175946282,['GPC6'],0.7783927016285586,0,0,1
225,Role of Osx and miRNAs in tooth development WP3971,0.3731690641148627,2.6933333333333334,2.6548825175946282,['NOTCH1'],0.7783927016285586,0,0,1
226,Serotonin Transporter Activity WP1455,0.3731690641148627,2.6933333333333334,2.6548825175946282,['IL1B'],0.7783927016285586,0,0,1
227,Sulfation Biotransformation Reaction WP692,0.3731690641148627,2.6933333333333334,2.6548825175946282,['SULT4A1'],0.7783927016285586,0,0,1
228,Synthesis and Degradation of Ketone Bodies WP311,0.3731690641148627,2.6933333333333334,2.6548825175946282,['BDH1'],0.7783927016285586,0,0,1
229,TCA Cycle Nutrient Utilization and Invasiveness of Ovarian Cancer WP2868,0.3731690641148627,2.6933333333333334,2.6548825175946282,['STAT3'],0.7783927016285586,0,0,1
230,EGFR Tyrosine Kinase Inhibitor Resistance WP4806,0.3744345278996448,1.1978461762351742,1.176690196400487,"['PDGFC', 'STAT3', 'GAB1', 'PDGFB', 'NRG1', 'GRB2', 'IGF1', 'FGF2']",0.7783927016285586,0,0,8
231,Alpha 6 Beta 4 signaling pathway WP244,0.3813498481696841,1.4262549594617906,1.3749641048488648,"['LAMA2', 'GAB1', 'GRB2']",0.7783927016285586,0,0,3
232,IL17 signaling pathway WP2112,0.3813498481696841,1.4262549594617906,1.3749641048488648,"['CEBPB', 'CEBPD', 'STAT3']",0.7783927016285586,0,0,3
233,Intracellular trafficking proteins involved in CMT neuropathy WP4856,0.3813498481696841,1.4262549594617906,1.3749641048488648,"['HSPB8', 'HSPB1', 'LITAF']",0.7783927016285586,0,0,3
234,Proximal tubule transport WP4917,0.3813498481696841,1.4262549594617906,1.3749641048488648,"['CA2', 'SLC4A2', 'ATP6V1D']",0.7783927016285586,0,0,3
235,Type II interferon signaling (IFNG) WP619,0.3813498481696841,1.4262549594617906,1.3749641048488648,"['OAS1', 'IL1B', 'PSMB9']",0.7783927016285586,0,0,3
236,Osteoblast differentiation WP4787,0.3849839375260015,1.2040590482951579,1.14933897896338,"['NOTCH1', 'WNT2B', 'WNT5B', 'WNT5A', 'PRKCQ', 'RBPJ', 'FGF2']",0.7783927016285586,0,0,7
237,Canonical and non-canonical Notch signaling WP3845,0.3876077942803435,1.6162109375,1.5317821631749677,"['NOTCH1', 'RBPJ']",0.7783927016285586,0,0,2
238,Deregulation of Rab and Rab Effector Genes in Bladder Cancer WP2291,0.3876077942803435,1.6162109375,1.5317821631749677,"['RPH3AL', 'RAB27A']",0.7783927016285586,0,0,2
239,Eicosanoid Synthesis WP167,0.3876077942803435,1.6162109375,1.5317821631749677,"['LTC4S', 'ALOX15B']",0.7783927016285586,0,0,2
240,Imatinib and Chronic Myeloid Leukemia WP3640,0.3876077942803435,1.6162109375,1.5317821631749677,"['NOP2', 'PIM1']",0.7783927016285586,0,0,2
241,Kallmann's Syndrome WP5074,0.3876077942803435,1.6162109375,1.5317821631749677,"['GRB2', 'PRKCQ']",0.7783927016285586,0,0,2
242,Mitochondrial LC-Fatty Acid Beta-Oxidation WP368,0.3876077942803435,1.6162109375,1.5317821631749677,"['CPT1A', 'ACSL1']",0.7783927016285586,0,0,2
243,Pregnane X receptor pathway WP2876,0.3876077942803435,1.6162109375,1.5317821631749677,"['ABCC3', 'HSP90AA1']",0.7783927016285586,0,0,2
244,Wnt/beta-catenin signaling pathway in leukemia WP3658,0.3876077942803435,1.6162109375,1.5317821631749677,"['ZBTB16', 'PPARD']",0.7783927016285586,0,0,2
245,Disruption of postsynaptic signaling by CNV WP4875,0.39890426724347283,1.2931506849315069,1.1884492171718506,"['RYR2', 'DLGAP1', 'GRIN2B', 'GRM1']",0.7978085344869457,0,0,4
246,DNA Replication WP466,0.4124700926537529,1.3468556533072662,1.1927640240151614,"['PRIM1', 'RPA3', 'MCM5']",0.8182605076936799,0,0,3
247,The influence of laminopathies on Wnt signaling WP4844,0.4124700926537529,1.3468556533072662,1.1927640240151614,"['CEBPB', 'CEBPD', 'SPP1']",0.8182605076936799,0,0,3
248,Pathways in clear cell renal cell carcinoma WP4018,0.42260115252981084,1.1546333940838356,0.9945162784151989,"['LDHA', 'TPI1', 'STAT3', 'PDGFB', 'ALDOC', 'HIF1A', 'KCNJ2']",0.8321815985903516,0,0,7
249,Fas ligand pathway and stress induction of heat shock proteins WP314,0.4248333795570869,1.2432635857293393,1.064306030876081,"['HSPB1', 'CYCS', 'ACTG1', 'LMNB1']",0.8321815985903516,0,0,4
250,Constitutive Androstane Receptor Pathway WP2875,0.42797910784646653,1.4691051136363635,1.246801447148118,"['ABCC3', 'HSP90AA1']",0.8321815985903516,0,0,2
251,Gastric Cancer Network 1 WP2361,0.42797910784646653,1.4691051136363635,1.246801447148118,"['NOTCH1', 'ECT2']",0.8321815985903516,0,0,2
252,PI3K/AKT/mTOR - VitD3 signaling WP4141,0.42797910784646653,1.4691051136363635,1.246801447148118,"['LDHA', 'SLC2A3']",0.8321815985903516,0,0,2
253,T-Cell antigen Receptor (TCR) pathway during Staphylococcus aureus infection WP3863,0.43240676280931384,1.1884254191392523,0.9963622677024173,"['MAP3K8', 'PRKCQ', 'GRB2', 'CALM2', 'PDK1']",0.8374676433856275,0,0,5
254,GDNF/RET signaling axis WP4830,0.44227054579717395,2.0197560975609754,1.6477846652022676,['ROBO2'],0.8399711916302917,0,0,1
255,Ketogenesis and Ketolysis WP4742,0.44227054579717395,2.0197560975609754,1.6477846652022676,['BDH1'],0.8399711916302917,0,0,1
256,Metastatic brain tumor WP2249,0.44227054579717395,2.0197560975609754,1.6477846652022676,['E2F3'],0.8399711916302917,0,0,1
257,NAD Biosynthesis II (from tryptophan) WP2485,0.44227054579717395,2.0197560975609754,1.6477846652022676,['HAAO'],0.8399711916302917,0,0,1
258,Thiamine metabolic pathways WP4297,0.44227054579717395,2.0197560975609754,1.6477846652022676,['SLC25A19'],0.8399711916302917,0,0,1
259,Metabolic reprogramming in colon cancer WP4290,0.45047100684973646,1.1970718272088134,0.9546187688157902,"['LDHA', 'PGAM1', 'SLC16A3', 'PAICS']",0.8489645898321956,0,0,4
260,Photodynamic therapy-induced AP-1 survival signaling. WP3611,0.45047100684973646,1.1970718272088134,0.9546187688157902,"['CDKN1A', 'HSP90AA1', 'JUNB', 'MAP2K6']",0.8489645898321956,0,0,4
261,Apoptosis Modulation by HSP70 WP384,0.4668980431125522,1.3465169270833333,1.0255670342645082,"['CYCS', 'HSPA1A']",0.860075342575754,0,0,2
262,Endothelin Pathways WP2197,0.4668980431125522,1.3465169270833333,1.0255670342645082,"['RAMP1', 'CALM2']",0.860075342575754,0,0,2
263,Heart Development WP1591,0.4668980431125522,1.3465169270833333,1.0255670342645082,"['NOTCH1', 'BHLHE40']",0.860075342575754,0,0,2
264,Monoamine Transport WP727,0.4668980431125522,1.3465169270833333,1.0255670342645082,"['IL1B', 'NECTIN2']",0.860075342575754,0,0,2
265,Photodynamic therapy-induced NFE2L2 (NRF2) survival signaling WP3612,0.4668980431125522,1.3465169270833333,1.0255670342645082,"['ABCC3', 'HMOX1']",0.860075342575754,0,0,2
266,Triacylglyceride synthesis WP325,0.4668980431125522,1.3465169270833333,1.0255670342645082,"['LIPC', 'GK']",0.860075342575754,0,0,2
267,Bladder cancer WP2828,0.4730397696936949,1.2118768328445748,0.9071816870191561,"['CDKN1A', 'RPS6KA5', 'TYMP']",0.8627575736973848,0,0,3
268,Photodynamic therapy-induced HIF-1 survival signaling WP3614,0.4730397696936949,1.2118768328445748,0.9071816870191561,"['LDHA', 'SLC2A3', 'HIF1A']",0.8627575736973848,0,0,3
269,Signaling of Hepatocyte Growth Factor Receptor WP313,0.47572955520091675,1.1541794800111826,0.85744656941398,"['PXN', 'STAT3', 'GAB1', 'GRB2']",0.8627575736973848,0,0,4
270,Synaptic Vesicle Pathway WP2267,0.477157760146921,1.1221297203177711,0.8302728790916633,"['SNAP25', 'UNC13C', 'CACNA1B', 'CACNA1A', 'SYN3']",0.8627575736973848,0,0,5
271,Translation inhibitors in chronically activated PDGFRA cells WP4566,0.477157760146921,1.1221297203177711,0.8302728790916633,"['EIF4A2', 'RPS6KA5', 'PIM1', 'PDK1', 'MAP2K6']",0.8627575736973848,0,0,5
272,Cholesterol metabolism (includes both Bloch and Kandutsch-Russell pathways) WP4718,0.500531256229419,1.114245225723733,0.7711526657370432,"['CH25H', 'ACSL1', 'SCD', 'CYP51A1']",0.8699127839783868,0,0,4
273,Common Pathways Underlying Drug Addiction WP2636,0.500531256229419,1.114245225723733,0.7711526657370432,"['GRM5', 'CALM2', 'GRM1', 'ACTG1']",0.8699127839783868,0,0,4
274,GABA receptor Signaling WP4159,0.5022401971224424,1.1540287669319926,0.7947528307044183,"['GAD2', 'GABRG3', 'GABRG1']",0.8699127839783868,0,0,3
275,Renin-angiotensin-aldosterone system (RAAS) WP4756,0.5022401971224424,1.1540287669319926,0.7947528307044183,"['CALM3', 'CALM2', 'CAMK1G']",0.8699127839783868,0,0,3
276,Cell Differentiation - Index WP2029,0.5037609104786924,1.615609756097561,1.1077484959181982,['STAT3'],0.8699127839783868,0,0,1
277,Cellular Proteostasis WP4918,0.5037609104786924,1.615609756097561,1.1077484959181982,['PFDN5'],0.8699127839783868,0,0,1
278,FOXP3 in COVID-19 WP5063,0.5037609104786924,1.615609756097561,1.1077484959181982,['STAT3'],0.8699127839783868,0,0,1
279,Glial Cell Differentiation WP2276,0.5037609104786924,1.615609756097561,1.1077484959181982,['GAP43'],0.8699127839783868,0,0,1
280,Glucuronidation WP698,0.5037609104786924,1.615609756097561,1.1077484959181982,['PGM5'],0.8699127839783868,0,0,1
281,Hedgehog Signaling Pathway Netpath WP47,0.5037609104786924,1.615609756097561,1.1077484959181982,['ARNTL'],0.8699127839783868,0,0,1
282,Pilocytic astrocytoma WP2253,0.5037609104786924,1.615609756097561,1.1077484959181982,['GRB2'],0.8699127839783868,0,0,1
283,Selective expression of chemokine receptors during T-cell polarization WP4494,0.5037609104786924,1.615609756097561,1.1077484959181982,['IL4R'],0.8699127839783868,0,0,1
284,DNA Mismatch Repair WP531,0.5041943482650242,1.2427884615384615,0.8510534275304966,"['POLE4', 'RPA3']",0.8699127839783868,0,0,2
285,Association Between Physico-Chemical Features and Toxicity Associated Pathways WP3680,0.5206736240204378,1.0628125161090778,0.6936253251029451,"['CDKN1A', 'TMSB4X', 'GRB2', 'PFN1', 'PFN2']",0.8920632019930578,0,0,5
286,Structural Pathway of Interleukin 1 (IL-1) WP2637,0.5206736240204378,1.0628125161090778,0.6936253251029451,"['RPS6KA5', 'IRAK2', 'MAP3K8', 'IL1RAP', 'MAP2K6']",0.8920632019930578,0,0,5
287,G Protein Signaling Pathways WP35,0.5294587837942828,1.0256026444631552,0.6521806773389223,"['GNG10', 'GNG3', 'ADCY9', 'PDE4D', 'PDE4B', 'PRKCQ', 'PDE7B', 'CALM2']",0.9039540211121901,0,0,8
288,Hippo-Merlin Signaling Dysregulation WP4541,0.5327805073882335,1.0279239896511732,0.6472279669431537,"['PPP1R14A', 'CDH20', 'INSR', 'ITGAX', 'CDH12', 'ITGAV', 'CDH18']",0.906466835486925,0,0,7
289,Thyroid stimulating hormone (TSH) signaling pathway WP2032,0.5368001732611483,1.0310387984981226,0.6414395187305626,"['CCND3', 'PDE4D', 'APEX1', 'STAT3', 'TSHR', 'MAP2K6']",0.9088621829822419,0,0,6
290,Prostaglandin Synthesis and Regulation WP98,0.5397528474445559,1.1538783482142858,0.7115320841310208,"['HPGDS', 'S100A6']",0.9088621829822419,0,0,2
291,SARS coronavirus and innate immunity WP4912,0.5397528474445559,1.1538783482142858,0.7115320841310208,"['IFNAR2', 'IKBKE']",0.9088621829822419,0,0,2
292,G13 Signaling Pathway WP524,0.5485007341829979,1.0421059276560822,0.6258540771087697,"['IQGAP1', 'IQGAP2', 'PFN1', 'CALM2']",0.9141678903049966,0,0,4
293,IL-6 signaling pathway WP364,0.5485007341829979,1.0421059276560822,0.6258540771087697,"['STAT3', 'GAB1', 'GRB2', 'JUNB']",0.9141678903049966,0,0,4
294,TGF-beta receptor signaling in skeletal dysplasias WP4816,0.5485007341829979,1.0421059276560822,0.6258540771087697,"['ADAMTSL2', 'STAT3', 'SPP1', 'TGFBR1']",0.9141678903049966,0,0,4
295,Amplification and Expansion of Oncogenic Pathways as Metastatic Traits WP3678,0.5584777484496167,1.346178861788618,0.7842037111351559,['NOTCH1'],0.9183023380547389,0,0,1
296,Aspirin and miRNAs WP4707,0.5584777484496167,1.346178861788618,0.7842037111351559,['PDK1'],0.9183023380547389,0,0,1
297,Estrogen Receptor Pathway WP2881,0.5584777484496167,1.346178861788618,0.7842037111351559,['STAT3'],0.9183023380547389,0,0,1
298,Ethanol metabolism resulting in production of ROS by CYP2E1 WP4269,0.5584777484496167,1.346178861788618,0.7842037111351559,['PRKCQ'],0.9183023380547389,0,0,1
299,3q29 copy number variation syndrome WP4906,0.5625636347292062,1.0094270323212537,0.5806739328802817,"['PXN', 'SLC40A1', 'DYNLL1', 'HIF1A', 'HAMP']",0.9219270268137494,0,0,5
300,Small cell lung cancer WP4658,0.5827999290588003,0.9846874178829937,0.5316438898646857,"['CDKN1A', 'LAMA2', 'CYCS', 'ITGAV', 'E2F3']",0.9338019230861244,0,0,5
301,Prion disease pathway WP3995,0.5844317742883685,1.0094086021505377,0.5421687333020118,"['HSPA5', 'STAT3', 'HSP90B1']",0.9338019230861244,0,0,3
302,Apoptosis Modulation and Signaling WP1772,0.592600454564228,0.9688235294117648,0.5069222600288922,"['CASP4', 'CASP1', 'CYCS', 'TNFRSF1B', 'TNFRSF10D', 'HSPA1A']",0.9338019230861244,0,0,6
303,Primary focal segmental glomerulosclerosis (FSGS) WP2572,0.5939429165125908,0.978710786929965,0.5098809791023418,"['CDKN1A', 'NOTCH1', 'ITGAV', 'TLR4']",0.9338019230861244,0,0,4
304,Senescence and Autophagy in Cancer WP615,0.6013935228252841,0.9577685001912809,0.48703081695288153,"['GABARAPL1', 'CDKN1A', 'CEBPB', 'MAP1LC3A', 'IL1B', 'PLAT', 'IGF1']",0.9338019230861244,0,0,7
305,Mitochondrial complex I assembly model OXPHOS system WP4324,0.6025210713761222,0.9611258803227462,0.4869377430722315,"['NDUFA7', 'NDUFS6', 'NDUFAB1', 'NDUFB2', 'TMEM70']",0.9338019230861244,0,0,5
306,16p11.2 distal deletion syndrome WP4950,0.6054123372639973,1.0093994140625,0.5065625575903804,"['INSR', 'GRB2']",0.9338019230861244,0,0,2
307,Base Excision Repair WP4752,0.6054123372639973,1.0093994140625,0.5065625575903804,"['POLE4', 'APEX1']",0.9338019230861244,0,0,2
308,Extracellular vesicle-mediated signaling in recipient cells WP2870,0.6054123372639973,1.0093994140625,0.5065625575903804,"['WNT5A', 'TGFBR1']",0.9338019230861244,0,0,2
309,Purinergic signaling WP4900,0.6054123372639973,1.0093994140625,0.5065625575903804,"['P2RY12', 'P2RY13']",0.9338019230861244,0,0,2
310,Alanine and aspartate metabolism WP106,0.607166554791098,1.1537282229965158,0.5756551606046539,['GAD2'],0.9338019230861244,0,0,1
311,BMP Signaling Pathway in Eyelid Development WP3927,0.607166554791098,1.1537282229965158,0.5756551606046539,['NOTCH1'],0.9338019230861244,0,0,1
312,ID signaling pathway WP53,0.607166554791098,1.1537282229965158,0.5756551606046539,['ID2'],0.9338019230861244,0,0,1
313,Mammary gland development pathway - Embryonic development (Stage 1 of 4) WP2813,0.607166554791098,1.1537282229965158,0.5756551606046539,['NRG3'],0.9338019230861244,0,0,1
314,Nanoparticle triggered regulated necrosis WP2513,0.607166554791098,1.1537282229965158,0.5756551606046539,['FTL'],0.9338019230861244,0,0,1
315,Purine metabolism WP4792,0.607166554791098,1.1537282229965158,0.5756551606046539,['IMPDH1'],0.9338019230861244,0,0,1
316,RalA downstream regulated genes WP2290,0.607166554791098,1.1537282229965158,0.5756551606046539,['YBX3'],0.9338019230861244,0,0,1
317,TCA cycle in senescence WP5050,0.607166554791098,1.1537282229965158,0.5756551606046539,['PDK1'],0.9338019230861244,0,0,1
318,TFs regulate miRNAs related to cardiac hypertrophy WP1559,0.607166554791098,1.1537282229965158,0.5756551606046539,['STAT3'],0.9338019230861244,0,0,1
319,Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling WP3850,0.6098298273215507,0.9689149560117302,0.4792014363773529,"['MAP1LC3A', 'IGF1', 'PDK1']",0.9338019230861244,0,0,3
320,Prader-Willi and Angelman Syndrome WP3998,0.6098298273215507,0.9689149560117302,0.4792014363773529,"['PCSK1', 'GABRG3', 'GABRG1']",0.9338019230861244,0,0,3
321,Hepatitis B infection WP4666,0.6303639789629218,0.9343012704174228,0.43114068543504175,"['CDKN1A', 'TICAM2', 'STAT3', 'CYCS', 'GRB2', 'IKBKE', 'JAK3', 'TLR4', 'TGFBR1', 'MAP2K6', 'TLR2']",0.9393816917126458,0,0,11
322,Aryl Hydrocarbon Receptor Netpath WP2586,0.6341673726799054,0.9315362057297542,0.42426105226869476,"['CDKN1A', 'HPGDS', 'HSP90AA1']",0.9393816917126458,0,0,3
323,Host-pathogen interaction of human coronaviruses - interferon induction WP4880,0.6341673726799054,0.9315362057297542,0.42426105226869476,"['IFNAR2', 'OAS1', 'IKBKE']",0.9393816917126458,0,0,3
324,mBDNF and proBDNF regulation of GABA neurotransmission WP4829,0.6341673726799054,0.9315362057297542,0.42426105226869476,"['STAT3', 'GABRG3', 'GABRG1']",0.9393816917126458,0,0,3
325,T-Cell Receptor and Co-stimulatory Signaling WP2583,0.6354753909732023,0.9499080882352942,0.43067114620316943,"['CALM2', 'PDK1']",0.9393816917126458,0,0,2
326,Ras signaling WP4223,0.636559996391096,0.9309285389167046,0.4204786424975343,"['GNG10', 'GNG3', 'INSR', 'PLA2G4C', 'RASA2', 'GAB1', 'CALM3', 'GRB2', 'KSR2', 'GRIN2B', 'CALM2', 'RASGRP3']",0.9393816917126458,0,0,12
327,Chemokine signaling pathway WP3929,0.6371580343447152,0.9274594985971581,0.41804083379551443,"['FGR', 'CX3CR1', 'GNG10', 'GNG3', 'ADCY9', 'CXCL12', 'PXN', 'STAT3', 'GRB2', 'JAK3']",0.9393816917126458,0,0,10
328,MET in type 1 papillary renal cell carcinoma WP4205,0.6403183957923734,0.9172157421422847,0.40888536071198145,"['CDKN1A', 'STAT3', 'GAB1', 'GRB2', 'JAK3']",0.9393816917126458,0,0,5
329,Cell-type Dependent Selectivity of CCK2R Signaling WP3679,0.650490846790129,1.009390243902439,0.4340661204607699,['RYR2'],0.9393816917126458,0,0,1
330,Galanin receptor pathway WP4970,0.650490846790129,1.009390243902439,0.4340661204607699,['CDKN1A'],0.9393816917126458,0,0,1
331,Neuroinflammation WP4919,0.650490846790129,1.009390243902439,0.4340661204607699,['TLR4'],0.9393816917126458,0,0,1
332,RAS and bradykinin pathways in COVID-19 WP4969,0.650490846790129,1.009390243902439,0.4340661204607699,['IL1B'],0.9393816917126458,0,0,1
333,Regulation of Wnt/B-catenin Signaling by Small Molecule Compounds WP3664,0.650490846790129,1.009390243902439,0.4340661204607699,['TCF4'],0.9393816917126458,0,0,1
334,Focal Adhesion WP306,0.6553930301258644,0.9148138743588441,0.3865273203986602,"['FGR', 'CCND3', 'LAMA2', 'PDGFC', 'PXN', 'PDGFB', 'SPP1', 'GRB2', 'ITGAV', 'IGF1', 'ACTG1']",0.9393816917126458,0,0,11
335,Cytosolic DNA-sensing pathway WP4655,0.656738128428535,0.8968253968253969,0.37708810897452494,"['IL1B', 'CASP1', 'IKBKE', 'POLR2K']",0.9393816917126458,0,0,4
336,DNA damage response WP707,0.656738128428535,0.8968253968253969,0.37708810897452494,"['CDKN1A', 'CCND3', 'CHEK2', 'CYCS']",0.9393816917126458,0,0,4
337,RAC1/PAK1/p38/MMP2 Pathway WP3303,0.656738128428535,0.8968253968253969,0.37708810897452494,"['STMN1', 'PXN', 'STAT3', 'GRB2']",0.9393816917126458,0,0,4
338,Kit receptor signaling pathway WP304,0.6583558963628334,0.8967243443247361,0.3748394005741735,"['STAT3', 'GRB2', 'SOCS6', 'JUNB', 'SH2B2']",0.9393816917126458,0,0,5
339,Fatty Acid Biosynthesis WP357,0.6637115365633594,0.8970269097222222,0.3676981986377887,"['ACSL1', 'SCD']",0.9393816917126458,0,0,2
340,IL-7 signaling pathway WP205,0.6637115365633594,0.8970269097222222,0.3676981986377887,"['STAT3', 'JAK3']",0.9393816917126458,0,0,2
341,Nanoparticle-mediated activation of receptor signaling WP2643,0.6637115365633594,0.8970269097222222,0.3676981986377887,"['PXN', 'GRB2']",0.9393816917126458,0,0,2
342,Physiological and pathological hypertrophy of the heart WP1528,0.6637115365633594,0.8970269097222222,0.3676981986377887,"['STAT3', 'CALM2']",0.9393816917126458,0,0,2
343,Melanoma WP4685,0.6758003683127273,0.8771238768470808,0.34370762193549703,"['CDKN1A', 'E2F3', 'CALM3', 'GRB2', 'CALM2']",0.9393816917126458,0,0,5
344,miRNA regulation of DNA damage response WP1530,0.6761522051593163,0.8724810916591739,0.3414341964149897,"['CDKN1A', 'CCND3', 'CHEK2', 'CYCS']",0.9393816917126458,0,0,4
345,p53 transcriptional gene network WP4963,0.6761522051593163,0.8724810916591739,0.3414341964149897,"['CDKN1A', 'NOTCH1', 'DRAM1', 'TNFRSF10D']",0.9393816917126458,0,0,4
346,Corticotropin-releasing hormone signaling pathway WP2355,0.6770296026994548,0.8802139037433155,0.3433188781221599,"['HSP90AA1', 'PRKCQ', 'TCF4', 'JUNB', 'TLR4', 'TBX19']",0.9393816917126458,0,0,6
347,Androgen receptor signaling pathway WP138,0.6791422696285035,0.8824061579980373,0.3414246896055282,"['CDKN1A', 'LIMK2', 'STAT3', 'DSTN', 'STUB1', 'CALR', 'RHOB']",0.9393816917126458,0,0,7
348,Integrated Cancer Pathway WP1971,0.6796004872697448,0.8647884373690825,0.3340246828414709,"['CDKN1A', 'CHEK2', 'BACH1']",0.9393816917126458,0,0,3
349,TGF-beta Receptor Signaling WP560,0.6796004872697448,0.8647884373690825,0.3340246828414709,"['STAT3', 'SPP1', 'TGFBR1']",0.9393816917126458,0,0,3
350,MAPK and NFkB signaling pathways inhibited by Yersinia YopJ WP3849,0.6890411706764614,0.8971273712737128,0.3341389071620642,['MAP2K6'],0.9393816917126458,0,0,1
351,NAD+ metabolism WP3644,0.6890411706764614,0.8971273712737128,0.3341389071620642,['NAMPT'],0.9393816917126458,0,0,1
352,Nanomaterial induced apoptosis WP2507,0.6890411706764614,0.8971273712737128,0.3341389071620642,['CYCS'],0.9393816917126458,0,0,1
353,Omega-3/Omega-6 FA synthesis WP4723,0.6890411706764614,0.8971273712737128,0.3341389071620642,['ACSL1'],0.9393816917126458,0,0,1
354,Ovarian infertility WP34,0.6890411706764614,0.8971273712737128,0.3341389071620642,['CEBPB'],0.9393816917126458,0,0,1
355,Riboflavin and CoQ disorders WP5037,0.6890411706764614,0.8971273712737128,0.3341389071620642,['RFK'],0.9393816917126458,0,0,1
356,Serotonin and anxiety WP3947,0.6890411706764614,0.8971273712737128,0.3341389071620642,['GRM1'],0.9393816917126458,0,0,1
357,Urea cycle and associated pathways WP4595,0.6890411706764614,0.8971273712737128,0.3341389071620642,['OAT'],0.9393816917126458,0,0,1
358,Vitamin A and carotenoid metabolism WP716,0.6890411706764614,0.8971273712737128,0.3341389071620642,['BCO2'],0.9393816917126458,0,0,1
359,Sphingolipid pathway WP1422,0.690157977584801,0.8497121710526315,0.3151028044117987,"['UGCG', 'B4GALT6']",0.9393816917126458,0,0,2
360,TLR4 Signaling and Tolerance WP3851,0.690157977584801,0.8497121710526315,0.3151028044117987,"['IKBKE', 'TLR4']",0.9393816917126458,0,0,2
361,Apoptosis WP254,0.6926423669657928,0.8583574718152833,0.3152244665880756,"['CASP4', 'CASP1', 'CYCS', 'IGF1', 'TNFRSF1B']",0.9401516892333476,0,0,5
362,B Cell Receptor Signaling Pathway WP23,0.6951972828783443,0.8719800350448681,0.3170167244695608,"['BCL6', 'GAB1', 'HCLS1', 'GRB2', 'E2F3', 'PIK3AP1', 'RASGRP3', 'MAP2K6']",0.9410128967137809,0,0,8
363,Glycogen Synthesis and Degradation WP500,0.7006905624508932,0.8348670239660229,0.29695294378701054,"['CALM3', 'PYGL', 'CALM2']",0.9451683430173218,0,0,3
364,Ebola Virus Pathway on Host WP4217,0.709688834959251,0.8639907290349769,0.29628718782621377,"['BST2', 'SCIN', 'RASA2', 'ITGAV', 'IQGAP1', 'IKBKE', 'TLR4', 'ACTG1', 'RHOB']",0.9451683430173218,0,0,9
365,"Non-genomic actions of 1,25 dihydroxyvitamin D3 WP4341",0.7126476627871002,0.8275377590446084,0.28034342931037504,"['IFI27L2', 'PRKCQ', 'TLR4', 'TLR2']",0.9451683430173218,0,0,4
366,Glycerophospholipid Biosynthetic Pathway WP2533,0.714865896641678,0.80712890625,0.27092113970807485,"['PGS1', 'GK']",0.9451683430173218,0,0,2
367,Envelope proteins and their potential roles in EDMD physiopathology WP4535,0.7207064712620145,0.8069403714565004,0.2642918039923874,"['ADCY9', 'BANF1', 'GRB2']",0.9451683430173218,0,0,3
368,IL-2 signaling pathway WP49,0.7207064712620145,0.8069403714565004,0.2642918039923874,"['STAT3', 'GRB2', 'JAK3']",0.9451683430173218,0,0,3
369,Cancer immunotherapy by PD-1 blockade WP4585,0.7233431196561136,0.8073170731707318,0.2614670655176135,['STAT3'],0.9451683430173218,0,0,1
370,Canonical and non-canonical TGF-B signaling WP3874,0.7233431196561136,0.8073170731707318,0.2614670655176135,['TGFBR1'],0.9451683430173218,0,0,1
371,FOXA2 pathway WP5066,0.7233431196561136,0.8073170731707318,0.2614670655176135,['ABCC3'],0.9451683430173218,0,0,1
372,Globo Sphingolipid Metabolism WP1424,0.7233431196561136,0.8073170731707318,0.2614670655176135,['ST6GALNAC5'],0.9451683430173218,0,0,1
373,Metabolism of Spingolipids in ER and Golgi apparatus WP4142,0.7233431196561136,0.8073170731707318,0.2614670655176135,['UGCG'],0.9451683430173218,0,0,1
374,SREBF and miR33 in cholesterol and lipid homeostasis WP2011,0.7233431196561136,0.8073170731707318,0.2614670655176135,['SCD'],0.9451683430173218,0,0,1
375,TP53 network WP1742,0.7233431196561136,0.8073170731707318,0.2614670655176135,['CDKN1A'],0.9451683430173218,0,0,1
376,Endometrial cancer WP4155,0.7297281149911902,0.8067514677103719,0.2541938819978905,"['CDKN1A', 'CTNNA3', 'GRB2', 'FGF2']",0.9484529876543321,0,0,4
377,Interferon type I signaling pathways WP585,0.7297281149911902,0.8067514677103719,0.2541938819978905,"['IFNAR2', 'RPS6KA5', 'STAT3', 'MAP2K6']",0.9484529876543321,0,0,4
378,Regucalcin in proximal tubule epithelial kidney cells WP4838,0.7378969282227373,0.7686011904761905,0.23361719866625788,"['PRKCQ', 'TGFBR1']",0.9562943053799348,0,0,2
379,Interleukin-11 Signaling Pathway WP2332,0.7396643708959088,0.7808154384637215,0.2354617264431316,"['FES', 'STAT3', 'GRB2']",0.9562943053799348,0,0,3
380,Cholesterol Biosynthesis Pathway WP197,0.7538644716415487,0.7338359201773836,0.20733996240383315,['CYP51A1'],0.961413222216142,0,0,1
381,Eicosanoid metabolism via cyclooxygenases (COX) WP4719,0.7538644716415487,0.7338359201773836,0.20733996240383315,['PPARD'],0.961413222216142,0,0,1
382,Hair Follicle Development: Organogenesis - Part 2 of 3 WP2839,0.7538644716415487,0.7338359201773836,0.20733996240383315,['WNT5A'],0.961413222216142,0,0,1
383,Oxidation by Cytochrome P450 WP43,0.7538644716415487,0.7338359201773836,0.20733996240383315,['CYP51A1'],0.961413222216142,0,0,1
384,Pathways of nucleic acid metabolism and innate immune sensing WP4705,0.7538644716415487,0.7338359201773836,0.20733996240383315,['OAS1'],0.961413222216142,0,0,1
385,PDGF Pathway WP2526,0.7575859391235198,0.7563233137829912,0.20996919038827708,"['STAT3', 'PDGFB', 'GRB2']",0.961413222216142,0,0,3
386,One-carbon metabolism and related pathways WP3940,0.759320238770708,0.7335759943181818,0.20197670256530337,"['GAD2', 'SOD2']",0.961413222216142,0,0,2
387,Parkinson's disease pathway WP2371,0.759320238770708,0.7335759943181818,0.20197670256530337,"['LRRK2', 'CYCS']",0.961413222216142,0,0,2
388,Wnt signaling WP428,0.7677118208913587,0.7753522187900249,0.20495726415064425,"['CCND3', 'WNT2B', 'WNT5B', 'WNT5A', 'ROR2']",0.9625661522171212,0,0,5
389,IL-5 signaling pathway WP127,0.7744974013834288,0.7333155602950324,0.18739217278317788,"['STAT3', 'CSF2RB', 'GRB2']",0.9625661522171212,0,0,3
390,Splicing factor NOVA regulated synaptic proteins WP4148,0.7744974013834288,0.7333155602950324,0.18739217278317788,"['EPB41L3', 'KCNMA1', 'GRIN2B']",0.9625661522171212,0,0,3
391,IL-1 signaling pathway WP195,0.7763796334907073,0.7501934191962863,0.18988420204921821,"['IRAK2', 'IL1B', 'IL1RAP', 'MAP2K6']",0.9625661522171212,0,0,4
392,BDNF-TrkB Signaling WP3676,0.7792101215663876,0.7015964673913043,0.17503045389713645,"['GAB1', 'GRB2']",0.9625661522171212,0,0,2
393,miRNA regulation of prostate cancer signaling pathways WP3981,0.7792101215663876,0.7015964673913043,0.17503045389713645,"['CDKN1A', 'GRB2']",0.9625661522171212,0,0,2
394,Prolactin Signaling Pathway WP2037,0.7809154766057402,0.760630532404413,0.18809507660145589,"['PTPN1', 'PXN', 'STAT3', 'GRB2', 'PPIB']",0.9625661522171212,0,0,5
395,Ebstein-Barr virus LMP1 signaling WP262,0.7810215435562062,0.6726016260162602,0.16623520360331678,['HSP90AA1'],0.9625661522171212,0,0,1
396,NAD+ biosynthetic pathways WP3645,0.7810215435562062,0.6726016260162602,0.16623520360331678,['NAMPT'],0.9625661522171212,0,0,1
397,Sleep regulation WP3591,0.7810215435562062,0.6726016260162602,0.16623520360331678,['PER3'],0.9625661522171212,0,0,1
398,ATM Signaling Network in Development and Disease  WP3878,0.790428656050415,0.7116612040710713,0.1673683952085312,"['HDAC4', 'CHEK2', 'HSPB1']",0.9625661522171212,0,0,3
399,AGE/RAGE pathway WP2324,0.7904413028573791,0.7330546166162605,0.17238796663040443,"['INSR', 'STAT3', 'CYCS', 'HIF1A']",0.9625661522171212,0,0,4
400,AMP-activated protein kinase (AMPK) signaling WP1403,0.7904413028573791,0.7330546166162605,0.17238796663040443,"['CDKN1A', 'CPT1A', 'INSR', 'LEPR']",0.9625661522171212,0,0,4
401,Pathways Regulating Hippo Signaling WP4540,0.7935323333001153,0.7464540936627126,0.17262571429160592,"['CDH20', 'INSR', 'CDH12', 'PRKCQ', 'CDH18']",0.9625661522171212,0,0,5
402,ATM Signaling Pathway WP2516,0.7976440299514563,0.6722819010416666,0.15199813693251335,"['CDKN1A', 'CHEK2']",0.9625661522171212,0,0,2
403,Kisspeptin/kisspeptin receptor system in the ovary WP4871,0.7976440299514563,0.6722819010416666,0.15199813693251335,"['PRKCQ', 'PDK1']",0.9625661522171212,0,0,2
404,PDGFR-beta pathway WP3972,0.7976440299514563,0.6722819010416666,0.15199813693251335,"['STAT3', 'GRB2']",0.9625661522171212,0,0,2
405,"4-hydroxytamoxifen, Dexamethasone, and Retinoic Acids Regulation of p27 Expression WP3879",0.8051848477637047,0.6207879924953096,0.13451445498639863,['MAP2K6'],0.9625661522171212,0,0,1
406,Inhibition of exosome biogenesis and secretion by Manumycin A in CRPC cells WP4301,0.8051848477637047,0.6207879924953096,0.13451445498639863,['RAB27A'],0.9625661522171212,0,0,1
407,Interactome of polycomb repressive complex 2 (PRC2)  WP2916,0.8051848477637047,0.6207879924953096,0.13451445498639863,['EZH2'],0.9625661522171212,0,0,1
408,Mitochondrial Gene Expression WP391,0.8051848477637047,0.6207879924953096,0.13451445498639863,['ESRRA'],0.9625661522171212,0,0,1
409,Serotonin Receptor 4/6/7 and NR3C Signaling WP734,0.8051848477637047,0.6207879924953096,0.13451445498639863,['RPS6KA5'],0.9625661522171212,0,0,1
410,Synaptic signaling pathways associated with autism spectrum disorder WP4539,0.805412494712285,0.6912442396313364,0.1495857490866746,"['CACNA1C', 'GRIN2B', 'GRM1']",0.9625661522171212,0,0,3
411,Thermogenesis WP4321,0.8090643400349676,0.7438914027149321,0.15761335581129252,"['CPT1A', 'ADCY9', 'ACSL1', 'GRB2', 'MGLL', 'ACTG1']",0.9636787560439912,0,0,6
412,Gastrin signaling pathway WP4659,0.8134471984569548,0.7519790644422637,0.1552643216625589,"['CDKN1A', 'PXN', 'STAT3', 'PRKCQ', 'TCF4', 'GRB2', 'RHOB']",0.9636787560439912,0,0,7
413,Fragile X Syndrome  WP4549,0.814673341461334,0.7711353794012427,0.1580581181706188,"['GRIP1', 'CPT1A', 'GRM5', 'GAB1', 'GRB2', 'GRIN2B', 'GRM1', 'PDK1', 'HCN1']",0.9636787560439912,0,0,9
414,MAPK Cascade WP422,0.8147009806158951,0.6453125,0.13224655448372186,"['GRB2', 'MAP2K6']",0.9636787560439912,0,0,2
415,Cell migration and invasion through p75NTR WP4561,0.8266841268435325,0.5763763066202091,0.10970320535901955,['STAT3'],0.9636787560439912,0,0,1
416,Hypothesized Pathways in Pathogenesis of Cardiovascular Disease WP3668,0.8266841268435325,0.5763763066202091,0.10970320535901955,['TGFBR1'],0.9636787560439912,0,0,1
417,Overview of interferons-mediated signaling pathway WP4558,0.8266841268435325,0.5763763066202091,0.10970320535901955,['IFNAR2'],0.9636787560439912,0,0,1
418,Photodynamic therapy-induced NF-kB survival signaling WP3617,0.8266841268435325,0.5763763066202091,0.10970320535901955,['IL1B'],0.9636787560439912,0,0,1
419,Signal Transduction of S1P Receptor WP26,0.8266841268435325,0.5763763066202091,0.10970320535901955,['RACGAP1'],0.9636787560439912,0,0,1
420,Sphingolipid Metabolism (general overview) WP4725,0.8266841268435325,0.5763763066202091,0.10970320535901955,['UGCG'],0.9636787560439912,0,0,1
421,Integrin-mediated Cell Adhesion WP185,0.8279770536622862,0.706909290856917,0.1334431522798032,"['PXN', 'ITGAX', 'GRB2', 'ITGAV', 'MAP2K6']",0.9636787560439912,0,0,5
422,Glioblastoma signaling pathways WP2261,0.8383680001672819,0.6946367658482219,0.12246316554568358,"['CDKN1A', 'GAB1', 'PRKCQ', 'GRB2', 'MAP2K6']",0.9652688263558773,0,0,5
423,Leptin signaling pathway WP2034,0.8383680001672819,0.6946367658482219,0.12246316554568358,"['PTPN1', 'IL1B', 'STAT3', 'LEPR', 'GRB2']",0.9652688263558773,0,0,5
424,Notch Signaling WP268,0.8450004545671379,0.5973668981481481,0.10060740615849414,"['NOTCH1', 'RBPJ']",0.9652688263558773,0,0,2
425,Target Of Rapamycin (TOR) Signaling WP1471,0.8450004545671379,0.5973668981481481,0.10060740615849414,"['PRR5', 'DDIT4']",0.9652688263558773,0,0,2
426,FGFR3 signaling in chondrocyte proliferation and terminal differentiation WP4767,0.84581283649635,0.5378861788617886,0.09007290122490993,['CDKN1A'],0.9652688263558773,0,0,1
427,Nucleotide metabolism WP404,0.84581283649635,0.5378861788617886,0.09007290122490993,['IMPDH1'],0.9652688263558773,0,0,1
428,Sphingolipid Metabolism (integrated pathway) WP4726,0.84581283649635,0.5378861788617886,0.09007290122490993,['UGCG'],0.9652688263558773,0,0,1
429,T-cell receptor (TCR) signaling pathway WP69,0.8482384569946766,0.6827802586364315,0.11238118118836954,"['IL1B', 'MAP3K8', 'PRKCQ', 'GRB2', 'OPRM1']",0.9652688263558773,0,0,5
430,Amino Acid metabolism WP3925,0.8503938830289056,0.6578537481528816,0.10660891349355855,"['ARG2', 'LDHA', 'OAT', 'IARS']",0.9652688263558773,0,0,4
431,TGF-beta Signaling Pathway WP366,0.8521732901005543,0.723692633716695,0.11576576766039294,"['EID2', 'CDKN1A', 'LIMK2', 'GRB2', 'JUNB', 'TGFBR1', 'PDK1', 'MAP2K6']",0.9652688263558773,0,0,8
432,RANKL/RANK signaling pathway WP2018,0.8565943403885181,0.62004662004662,0.09597752530536846,"['CALCR', 'TNFRSF11A', 'MAP2K6']",0.9652688263558773,0,0,3
433,Initiation of transcription and translation elongation at the HIV-1 LTR WP3414,0.8583985506553554,0.5759626116071429,0.08794187431628493,"['HDAC4', 'SUPT4H1']",0.9652688263558773,0,0,2
434,Follicle Stimulating Hormone (FSH) signaling pathway WP2035,0.8628321345793352,0.5042073170731707,0.07438828734794117,['SGK1'],0.9652688263558773,0,0,1
435,Host-pathogen interaction of human coronaviruses - autophagy WP4863,0.8628321345793352,0.5042073170731707,0.07438828734794117,['MAP1LC3A'],0.9652688263558773,0,0,1
436,MTHFR deficiency WP4288,0.8628321345793352,0.5042073170731707,0.07438828734794117,['CYCS'],0.9652688263558773,0,0,1
437,Tryptophan metabolism WP465,0.8628321345793352,0.5042073170731707,0.07438828734794117,['HAAO'],0.9652688263558773,0,0,1
438,Vitamin D in inflammatory diseases WP4482,0.8628321345793352,0.5042073170731707,0.07438828734794117,['MAP2K6'],0.9652688263558773,0,0,1
439,IL-3 signaling pathway WP286,0.8673903168830679,0.6044721407624634,0.08599596113612788,"['STAT3', 'CSF2RB', 'GRB2']",0.9652882724761489,0,0,3
440,Male infertility WP4673,0.8699522497901906,0.6319020758988527,0.08803467252795533,"['PACRG', 'INSR', 'SOD2', 'ARNTL']",0.9652882724761489,0,0,4
441,Amyotrophic lateral sclerosis (ALS) WP2447,0.8707294212948118,0.5560344827586207,0.07696851909068235,"['CASP1', 'MAP2K6']",0.9652882724761489,0,0,2
442,Thymic Stromal LymphoPoietin (TSLP) Signaling Pathway WP2203,0.8707294212948118,0.5560344827586207,0.07696851909068235,"['FES', 'STAT3']",0.9652882724761489,0,0,2
443,miRNA regulation of p53 pathway in prostate cancer WP3982,0.8779744333518663,0.4744906743185079,0.06174917482990076,['CHEK2'],0.9699333534081203,0,0,1
444,Head and Neck Squamous Cell Carcinoma WP4674,0.8788783855371538,0.619674845702243,0.08000544246973094,"['CDKN1A', 'NOTCH1', 'DDIT4', 'GAB1']",0.9699333534081203,0,0,4
445,SARS-CoV-2 innate immunity evasion and cell-specific immune response WP5039,0.8820653149420576,0.5374348958333334,0.06744226034798773,"['IFNAR2', 'CXCL12']",0.9712629310597938,0,0,2
446,Microglia Pathogen Phagocytosis Pathway WP3937,0.8924755326997386,0.5200352822580645,0.05915722719890011,"['FCER1G', 'NCF4']",0.9772228709030181,0,0,2
447,ErbB signaling pathway WP673,0.8974581204751082,0.619302343102539,0.06700159104366911,"['CDKN1A', 'NRG3', 'GAB1', 'NRG1', 'GRB2']",0.9772228709030181,0,0,5
448,Eukaryotic Transcription Initiation WP405,0.9020262002709666,0.50372314453125,0.05193975604730244,"['POLR2I', 'POLR2K']",0.9772228709030181,0,0,2
449,Nucleotide Excision Repair WP4753,0.9020262002709666,0.50372314453125,0.05193975604730244,"['POLE4', 'RPA3']",0.9772228709030181,0,0,2
450,Ethanol effects on histone modifications WP3996,0.9034325724878922,0.4244415917843389,0.04310365693454664,['HDAC4'],0.9772228709030181,0,0,1
451,Intraflagellar transport proteins binding to dynein WP4532,0.9034325724878922,0.4244415917843389,0.04310365693454664,['DYNLL1'],0.9772228709030181,0,0,1
452,miRNAs involvement in the immune response in sepsis WP4329,0.9034325724878922,0.4244415917843389,0.04310365693454664,['TLR4'],0.9772228709030181,0,0,1
453,Nephrotic syndrome WP4758,0.9034325724878922,0.4244415917843389,0.04310365693454664,['E2F3'],0.9772228709030181,0,0,1
454,Copper homeostasis WP3286,0.9107801255251272,0.4883996212121212,0.045642783880912495,"['STEAP3', 'SCO2']",0.9808401351809062,0,0,2
455,Neurodegeneration with brain iron accumulation (NBIA) subtypes pathway WP4577,0.9107801255251272,0.4883996212121212,0.045642783880912495,"['MAP1LC3A', 'FTL']",0.9808401351809062,0,0,2
456,Integrated breast cancer pathway WP1984,0.915026901834977,0.6497985751423866,0.057703291704491164,"['ITPKC', 'USP15', 'CHEK2', 'MAP3K7CL', 'FAU', 'BACH1', 'TGFBR1', 'RASGRP3']",0.9832525918840761,0,0,8
457,SARS-CoV-2 mitochondrial interactions WP5038,0.9235833801267237,0.38392566782810683,0.030519862414239447,['IKBKE'],0.9879203729524412,0,0,1
458,22q11.2 copy number variation syndrome WP4657,0.9247807865277256,0.5140076121544893,0.04019465360544838,"['OAT', 'EMC10', 'ARNTL']",0.9879203729524412,0,0,3
459,Angiopoietin Like Protein 8 Regulatory Pathway WP3915,0.930358548145243,0.6117570508170841,0.04415982433165923,"['PTPN1', 'RPS6KA5', 'SCD', 'INSR', 'FLOT2', 'MAP3K8', 'MAP2K6']",0.9879203729524412,0,0,7
460,Overview of leukocyte-intrinsic Hippo pathway functions WP4542,0.9320236329244923,0.36643015521064304,0.025795622992030122,['VMP1'],0.9879203729524412,0,0,1
461,PI3K-AKT-mTOR signaling pathway and therapeutic opportunities WP3844,0.9320236329244923,0.36643015521064304,0.025795622992030122,['PDK1'],0.9879203729524412,0,0,1
462,Regulation of Microtubule Cytoskeleton WP2038,0.9328386262520308,0.4475368923611111,0.03111413212131454,"['STMN1', 'STAT3']",0.9879203729524412,0,0,2
463,Chromosomal and microsatellite instability in colorectal cancer  WP4216,0.9363815430963545,0.4929080136453408,0.03239995477646294,"['CDKN1A', 'CYCS', 'TGFBR1']",0.9879203729524412,0,0,3
464,Pancreatic adenocarcinoma pathway WP4263,0.9379242541696172,0.5276699496326714,0.033816301624547955,"['CDKN1A', 'STAT3', 'E2F3', 'TGFBR1']",0.9879203729524412,0,0,4
465,Wnt Signaling Pathway WP363,0.9389658792682986,0.4353885135135135,0.027419086998114146,"['TCF4', 'ROR2']",0.9879203729524412,0,0,2
466,Tumor suppressor activity of SMARCB1 WP4204,0.939532436318036,0.3504559915164369,0.021858969003111774,['EZH2'],0.9879203729524412,0,0,1
467,Novel intracellular components of RIG-I-like receptor (RLR) pathway WP3865,0.9445598710317042,0.42387952302631576,0.024176479337251647,"['CXCL12', 'IKBKE']",0.9889622581314853,0,0,2
468,Rett syndrome causing genes WP4312,0.9445598710317042,0.42387952302631576,0.024176479337251647,"['TCF4', 'GRIN2B']",0.9889622581314853,0,0,2
469,Energy Metabolism WP1541,0.9496635856943562,0.41296073717948717,0.02132838035076021,"['ESRRA', 'PPARD']",0.9921858358000735,0,0,2
470,Neural Crest Cell Migration during Development WP4564,0.952155193372319,0.32234146341463416,0.015803512040116038,['STAT3'],0.9926724356434816,0,0,1
471,Translation Factors WP107,0.9585573194141481,0.39272103658536583,0.016622278046605182,"['EIF4A2', 'EEF1B2']",0.9955304476850568,0,0,2
472,Brain-derived neurotrophic factor (BDNF) signaling pathway WP2380,0.958959941443565,0.5787005079735924,0.024251009682664335,"['GRIP1', 'RPS6KA5', 'STAT3', 'SPP1', 'GRB2', 'YBX1', 'GRIN2B', 'SH2B2']",0.9955304476850568,0,0,8
473,Neural Crest Cell Migration in Cancer WP4565,0.9663285318086541,0.2877003484320558,0.009854141886082026,['STAT3'],0.9997557845046042,0,0,1
474,Sterol regulatory element-binding proteins (SREBP) signaling WP1982,0.9681065646671839,0.42331635540464063,0.01372099971894948,"['SCD', 'CYP51A1', 'SEC24D']",0.9997557845046042,0,0,3
475,Endoderm differentiation WP2853,0.9719319952559516,0.4527989856949919,0.012890933871230704,"['NOTCH1', 'TCF4', 'EZH2', 'NME1']",0.9997557845046042,0,0,4
476,Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms WP4534,0.9763058612761595,0.2597639653815893,0.006228973435176534,['ACTG1'],0.9997557845046042,0,0,1
477,Histone Modifications WP2369,0.9789255253261374,0.25161585365853656,0.005359345100587754,['EZH2'],0.9997557845046042,0,0,1
478,Pathways affected in adenoid cystic carcinoma WP3651,0.9792595025507318,0.3351643880208333,0.007024577206318152,"['NOTCH1', 'CHEK2']",0.9997557845046042,0,0,2
479,EGF/EGFR signaling pathway WP437,0.9813205654134951,0.5214752343987095,0.00983298847586911,"['PLSCR1', 'RPS6KA5', 'LIMK2', 'STMN1', 'STAT3', 'GAB1', 'GRB2', 'IQGAP1']",0.9997557845046042,0,0,8
480,Mesodermal commitment pathway WP2857,0.9844476435570371,0.3708549515001128,0.005812989323997158,"['BHLHE40', 'RPL38', 'TCF4']",0.9997557845046042,0,0,3
481,DNA IR-damage and cellular response via ATR WP4016,0.9846584956723331,0.31533394607843135,0.0048751898314859776,"['BCL6', 'CHEK2']",0.9997557845046042,0,0,2
482,DNA Repair Pathways Full Network WP4946,0.9878419057676505,0.39641467951970233,0.004849185555682131,"['POLE4', 'CENPX', 'RPA3', 'APEX1']",0.9997557845046042,0,0,4
483,Proteasome Degradation WP183,0.9897768927598765,0.2922585227272727,0.0030031673608093244,"['H2AFZ', 'PSMB9']",0.9997557845046042,0,0,2
484,DNA IR-double strand breaks and cellular response via ATM WP3959,0.9917489395152909,0.20109756097560977,0.0016661513887139185,['CHEK2'],0.9997557845046042,0,0,1
485,Ciliopathies WP4803,0.9949131284063863,0.3524225285477732,0.0017973033606380852,"['KIAA0586', 'LRRC6', 'CCDC65', 'DNAAF4']",0.9997557845046042,0,0,4
486,Ciliary landscape WP4352,0.9961399580614897,0.45814779324728033,0.0017718916884285813,"['DOCK5', 'TBC1D4', 'MCM5', 'IQGAP1', 'IQGAP2', 'DYNLL1', 'COX6C', 'COPS8', 'CALM2']",0.9997557845046042,0,0,9
487,Joubert Syndrome WP4656,0.9971286724775601,0.1639820806371329,0.000471523534995225,['KIAA0586'],0.9997557845046042,0,0,1
488,16p11.2 proximal deletion syndrome WP4949,0.9991111500680564,0.1360231500620091,0.00012095793236749914,['MAP2K6'],0.9997557845046042,0,0,1
489,Genes related to primary cilium development (based on CRISPR) WP4536,0.9995049474529035,0.1253201219512195,6.205540718576299e-05,['DYNLL1'],0.9997557845046042,0,0,1
490,mRNA Processing WP411,0.9997557845046042,0.2220321494515043,5.423031358309883e-05,"['SNRPD1', 'SNRPE', 'YBX1']",0.9997557845046042,0,0,3
